Management of stroke in infants and children: A scientific statement from a special writing group of the american heart association stroke council and the council on cardiovascular disease in the young

Stroke

Volumn 39, Issue 9, 2008, Pages 2644-2691

  Roach, E Steve ^a   Golomb, Meredith R ^a   Adams, Robert ^a   Biller, Jose ^a   Daniels, Stephen ^a   Deveber, Gabrielle ^a   Ferriero, Donna ^a   Jones, Blaise V ^a   Kirkham, Fenella J ^a   Scott, R Michael ^a   Smith, Edward R ^a  

^a NONE

Author keywords

AHA Scientific Statements; Children; Stroke

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; DALTEPARIN; DIPYRIDAMOLE; ENOXAPARIN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; REVIPARIN; TICLOPIDINE; TINZAPARIN; TISSUE PLASMINOGEN ACTIVATOR; WARFARIN; ANTICOAGULANT AGENT;

ARTERIOVENOUS MALFORMATION; ARTERY DISSECTION; BRAIN VASCULITIS; CARDIOVASCULAR DISEASE; CEREBRAL VENOUS SINUS THROMBOSIS; CEREBROVASCULAR ACCIDENT; CHILDHOOD DISEASE; CLINICAL EVALUATION; CLINICAL FEATURE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONVENTIONAL ANGIOGRAPHY; DIAGNOSTIC PROCEDURE; DISEASE CLASSIFICATION; DOPPLER ECHOGRAPHY; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; EPISTAXIS; EVIDENCE BASED PRACTICE; FAMILY HISTORY; FIBRINOLYTIC THERAPY; FIBROMUSCULAR DYSPLASIA; GASTROINTESTINAL SYMPTOM; HEART DISEASE; HUMAN; INTRACRANIAL ANEURYSM; LOW DRUG DOSE; MAGNETIC RESONANCE ANGIOGRAPHY; MEDICAL SOCIETY; MIGRAINE; MOYAMOYA DISEASE; NEUROIMAGING; NUCLEAR MEDICINE; PERINATAL MORBIDITY; PRIMARY PREVENTION; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SCREENING; SECONDARY PREVENTION; SICKLE CELL ANEMIA; STROKE; THROMBOPHILIA; TRANSIENT ISCHEMIC ATTACK; VEIN MALFORMATION; VEIN THROMBOSIS; AGE; BRAIN EMBOLISM; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CHILD; EVIDENCE BASED MEDICINE; INFANT; NEWBORN; PRACTICE GUIDELINE; PRESCHOOL CHILD;

AGE FACTORS; ANEMIA, SICKLE CELL; ANTICOAGULANTS; BRAIN ISCHEMIA; CHILD; CHILD, PRESCHOOL; EVIDENCE-BASED MEDICINE; HUMANS; INFANT; INFANT, NEWBORN; INTRACRANIAL EMBOLISM; INTRACRANIAL HEMORRHAGES; MOYAMOYA DISEASE; STROKE;

EID: 52449090507     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.108.189696     Document Type: Review

References (524)

1. Ganesan V, Prengler M, McShane MA, Wade AM, Kirkham FJ. Investigation of risk factors in children with arterial ischemic stroke. Ann Neurol. 2003;53:167-173.
2. Standridge S, de los Reyes E. Inflammatory bowel disease and cerebro-vascular arterial and venous thromboembolic events in 4 pediatric patients: a case series and review of the literature. J Child Neurol. 2008;23:59-66.
3. Kieslich M, Fiedler A, Heller C, Kreuz W, Jacobi G. Minor head injury as cause and co-factor in the aetiology of stroke in childhood: a report of eight cases. J Neurol Neurosurg Psychiatry. 2002;73:13-16.
4. deVeber G, Andrew M, Adams C, Bjornson B, Booth F, Buckley DJ, Camfield CS, David M, Humphreys P, Langevin P, MacDonald EA, Gillett J, Meaney B, Shevell M, Sinclair DB, Yager J; Canadian Pediatric Ischemic Stroke Study Group. Cerebral sinovenous thrombosis in children. N Engl J Med. 2001;345:417-423.
5. Heller C, Heinecke A, Junker R, Knöfler R, Kosch A, Kurnik K, Schobess R, von Eckardstein A, Sträter R, Zieger B, Nowak-Göttl U; Childhood Stroke Study Group. Cerebral venous thrombosis in children: a multifactorial origin. Circulation. 2003;108:1362-1367.
6. Sébire G, Tabarki B, Saunders DE, Leroy I, Liesner R, Saint-Martin C, Husson B, Williams AN, Wade A, Kirkham FJ. Cerebral venous sinus thrombosis in children: risk factors, presentation, diagnosis and outcome. Brain. 2005;128:477-489.
7. Nowak-Göttl U, Sträter R, Heinecke A, Junker R, Koch HG, Schuierer G, von Eckardstein A. Lipoprotein (a) and genetic polymorphisms of clotting factor V, prothrombin, and methylenetetrahydrofolate reductase are risk factors of spontaneous ischemic stroke in childhood. Blood. 1999;94:3678-3682.
8. Chabrier S, Rodesch G, Lasjaunias P, Tardieu M, Landrieu P, Sébire G. Transient cerebral arteriopathy: a disorder recognized by serial angiograms in children with stroke. J Child Neurol. 1998;13:27-32.
9. Schoenberg BS, Mellinger JF, Schoenberg DG. Cerebrovascular disease in infants and children: a study of incidence, clinical features, and survival. Neurology. 1978;28:763-768.
10. Broderick J, Talbot GT, Prenger E, Leach A, Brott T. Stroke in children within a major metropolitan area: the surprising importance of intracerebral hemorrhage. J Child Neurol. 1993;8:250-255.
11. Fullerton HJ, Wu YW, Zhao S, Johnston SC. Risk of stroke in children: ethnic and gender disparities. Neurology. 2003;61:189 -194.
12. Zahuranec DB, Brown DL, Lisabeth LD, Morgenstern LB. Is it time for a large, collaborative study of pediatric stroke? Stroke. 2005;36: 1825-1829.
13. Chung B, Wong V. Pediatric stroke among Hong Kong Chinese subjects. Pediatrics. 2004;114:e206-e212.
14. Earley CJ, Kittner SJ, Feeser BR, Gardner J, Epstein A, Wozniak MA, Wityk R, Stern BJ, Price TR, Macko RF, Johnson C, Sloan MA, Buchholz D. Stroke in children and sickle-cell disease: Baltimore-Washington Cooperative Young Stroke Study. Neurology. 1998;51: 169-176.
15. Giroud M, Lemesle M, Gouyon JB, Nivelon JL, Milan C, Dumas R. Cerebrovascular disease in children under 16 years of age in the city of Dijon, France: a study of incidence and clinical features from 1985 to 1993. J Clin Epidemiol. 1995;48:1343-1348.
16. Lynch JK, Hirtz DG, DeVeber G, Nelson KB. Report of the National Institute of Neurological Disorders and Stroke workshop on perinatal and childhood stroke. Pediatrics. 2002;109:116-123.
17. Nelson KB, Lynch JK. Stroke in newborn infants. Lancet Neurol. 2004;3:150-158.
18. Schoenberg BS. Risk factors for stroke in infants and children. Adv Neurol. 1979;25:313-324.
19. Ozduman K, Pober BR, Barnes P, Copel JA, Ogle EA, Duncan CC, Ment LR. Fetal stroke. Pediatr Neurol. 2004;30:151-162.
20. Golomb MR, MacGregor DL, Domi T, Armstrong DC, McCrindle BW, Mayank S, deVeber GA. Presumed pre- or perinatal arterial ischemic stroke: risk factors and outcomes. Ann Neurol. 2001;50:163-168.
21. Wu YW, Miller SP, Chin K, Collins AE, Lomeli SC, Chuang NA, Barkovich AJ, Ferriero DM. Multiple risk factors in neonatal sinovenous thrombosis. Neurology. 2002;59:438-440.
22. Günther G, Junker R, Sträter R, Schobess R, Kurnik K, Heller C, Kosch A, Nowak-Göttl U; Childhood Stroke Study Group. Symptomatic ischemic stroke in full-term neonates: role of acquired and genetic prothrombotic risk factors. Stroke. 2000;31:2437-2441.
23. Lee J, Croen LA, Backstrand KH, Yoshida CK, Henning LH, Lindan C, Ferriero DM, Fullerton HJ, Barkovich AJ, Wu YW. Maternal and infant characteristics associated with perinatal arterial stroke in the infant. JAMA. 2005;293:723-729.
24. Golomb MR, Dick PT, MacGregor DL, Armstrong DC, DeVeber GA. Cranial ultrasonography has a low sensitivity for detecting arterial is-chemic stroke in term neonates. J Child Neurol. 2003;18:98-103.
25. Estan J, Hope P. Unilateral neonatal cerebral infarction in full term infants. Arch Dis Child Fetal Neonatal Ed. 1997;76:F88-F93.
26. Trauner DA, Chase C, Walker P, Wulfeck B. Neurologic profiles of infants and children after perinatal stroke. Pediatr Neurol. 1993;9: 383-386.
27. Sreenan C, Bhargava R, Robertson CM. Cerebral infarction in the term newborn: clinical presentation and long-term outcome. J Pediatr. 2000; 137:351-355.
28. Coker SB, Beltran RS, Myers TF, Hmura L. Neonatal stroke: description of patients and investigation into pathogenesis. Pediatr Neurol. 1988;4: 219-223.
29. Lee J, Croen LA, Lindan C, Nash KB, Yoshida CK, Ferriero DM, Barkovich AJ, Wu YW. Predictors of outcome in perinatal arterial stroke: a population-based study. Ann Neurol. 2005;58:303-308.
30. Volpe JJ. Neurology of the Newborn. 4th ed. Philadelphia, Pa: WB Saunders Co; 2001.
31. Carvalho KS, Bodensteiner JB, Connolly PJ, Garg BP. Cerebral venous thrombosis in children. J Child Neurol. 2001;16:574-580.
32. Fitzgerald KC, Williams LS, Garg BP, Carvalho KS, Golomb MR. Cerebral sinovenous thrombosis in the neonate. Arch Neurol. 2006;63: 405-409.
33. Sandberg DI, Lamberti-Pasculli M, Drake JM, Humphreys RP, Rutka JT. Spontaneous intraparenchymal hemorrhage in full-term neonates. Neurosurgery. 2001;48:1042-1048; discussion 1048-1049.
34. Giroud M, Fayolle H, Martin D, Baudoin N, André N, Gouyon JB, Nivelon JL, Dumas R. Late thalamic atrophy in infarction of the middle cerebral artery territory in neonates. A prospective clinical and radiological study in four children. Childs Nerv Syst. 1995;11:133-136.
35. Ferri R, Elia M, Musumeci SA, Cosentino FI, Roccasalva G, Spada RS, Toscano G. Somatosensory evoked potentials in patients affected by unilateral cerebrovascular lesions with onset during the perinatal period or adulthood. J Child Neurol. 2001;16:541-547.
36. Mercuri E, Anker S, Guzzetta A, Barnett A, Haataja L, Rutherford M, Cowan F, Dubowitz L, Braddick O, Atkinson J. Neonatal cerebral infarction and visual function at school age. Arch Dis Child Fetal Neonatal Ed. 2003;88:F487-F491.
37. Ballantyne AO, Trauner DA. Facial recognition in children after perinatal stroke. Neuropsychiatry Neuropsychol Behav Neurol. 1999;12: 82-87.
38. Schatz AM, Ballantyne AO, Trauner DA. A hierarchical analysis of block design errors in children with early focal brain damage. Dev Neuropsychol. 2000;17:75-83.
39. Stiles J, Stern C, Trauner D, Nass R. Developmental change in spatial grouping activity among children with early focal brain injury: evidence from a modeling task. Brain Cogn. 1996;31:46-62.
40. Stiles J, Trauner D, Engel M, Nass R. The development of drawing in children with congenital focal brain injury: evidence for limited functional recovery. Neuropsychologia. 1997;35:299-312.
41. Clancy R, Malin S, Laraque D, Baumgart S, Younkin D. Focal motor seizures heralding stroke in full-term neonates. Am J Dis Child. 1985; 139:601-606.
42. Mercuri E, Rutherford M, Cowan F, Pennock J, Counsell S, Papad-imitriou M, Azzopardi D, Bydder G, Dubowitz L. Early prognostic indicators of outcome in infants with neonatal cerebral infarction: a clinical, electroencephalogram, and magnetic resonance imaging study. Pediatrics. 2000;106:614-616.
43. Sran SK, Baumann RJ. Outcome of neonatal strokes. Am J Dis Child. 1988;142:1086-1088.
44. deVeber GA, MacGregor D, Curtis R, Mayank S. Neurologic outcome in survivors of childhood arterial ischemic stroke and sinovenous thrombosis. J Child Neurol. 2000;15:316-324.
45. Koelfen W, Freund M, Varnholt V. Neonatal stroke involving the middle cerebral artery in term infants: clinical presentation, EEG and imaging studies, and outcome. Dev Med Child Neurol. 1995;37: 204-212.
46. de Vries LS, Groenendaal F, Eken P, van Haastert IC, Rademaker KJ, Meiners LC. Infarcts in the vascular distribution of the middle cerebral artery in preterm and fullterm infants. Neuropediatrics. 1997;28:88-96.
47. Mercuri E, Barnett A, Rutherford M, Guzzetta A, Haataja L, Cioni G, Cowan F, Dubowitz L. Neonatal cerebral infarction and neuromotor outcome at school age. Pediatrics. 2004;113:95-100.
48. Golomb MR, deVeber GA, MacGregor DL, Domi T, Whyte H, Stephens D, Dick PT. Independent walking after neonatal arterial ischemic stroke and sinovenous thrombosis. J Child Neurol. 2003;18:530-536.
49. Shevell MI, Silver K, O'Gorman AM, Watters GV, Montes JL. Neonatal dural sinus thrombosis. Pediatr Neurol. 1989;5:161-165.
50. Shields WD, Shewmon DA, Chugani HT, Peacock WJ. Treatment of infantile spasms: medical or surgical? Epilepsia. 1992;33(suppl 4):S26-S29.
51. Di Rocco C, Caldarelli M, Guzzetta F, Torrioli G. Surgical indication in children with congenital hemiparesis. Childs Nerv Syst. 1993;9:72- 80.
52. Kurnik K, Kosch A, Sträter R, Schobess R, Heller C, Nowak-Gottl U; Stroke Study Unit. Recurrent thromboembolism in infants and children suffering from symptomatic neonatal arterial stroke: a prospective follow-up study. Stroke. 2003;34:2887-2892.
53. Escuriola Ettingshausen C, Halimeh S, Kurnik K, Schobess R, Wermes C, Junker R, Kreuz W, Pollmann H, Nowak-Göttl U. Symptomatic onset of severe hemophilia A in childhood is dependent on the presence of prothrombotic risk factors. Thromb Haemost. 2001;85:218-220.
54. Barron TF, Gusnard DA, Zimmerman RA, Clancy RR. Cerebral venous thrombosis in neonates and children. Pediatr Neurol. 1992;8:112-116.
55. Mercuri E, Cowan F, Gupte G, Manning R, Laffan M, Rutherford M, Edwards AD, Dubowitz L, Roberts I. Prothrombotic disorders and abnormal neurodevelopmental outcome in infants with neonatal cerebral infarction. Pediatrics. 2001;107:1400 -1404.
56. Ramaswamy V, Miller SP, Barkovich AJ, Partridge JC, Ferriero DM. Perinatal stroke in term infants with neonatal encephalopathy. Neurology. 2004;62:2088-2091.
57. Bergman I, Bauer RE, Barmada MA, Latchaw RE, Taylor HG, David R, Painter MJ. Intracerebral hemorrhage in the full-term neonatal infant. Pediatrics. 1985;75:488-496.
58. deVeber G, Chan A, Monagle P, Marzinotto V, Armstrong D, Mas-sicotte P, Leaker M, Andrew M. Anticoagulation therapy in pediatric patients with sinovenous thrombosis: a cohort study. Arch Neurol. 1998; 55:1533-1537.
59. Shiozaki A, Arai T, Izumi R, Niiya K, Sakuragawa N. Congenital antithrombin III deficient neonate treated with antithrombin III concentrates. Thromb Res. 1993;70:211-216.
60. Petaja J, Peltola K, Rautiainen P. Disappearance of symptomatic venous thrombosis after neonatal cardiac operations during antithrombin III substitution. J Thorac Cardiovasc Surg. 1999;118:955-956; discussion 957.
61. Dreyfus M, Masterson M, David M, Rivard GE, Müller FM, Kreuz W, Beeg T, Minford A, Allgrove J, Cohen JD, Christoph J, Bergmann F, Mitchell VE, Haworth C, Nelson K, Schwarz HP. Replacement therapy with a monoclonal antibody purified protein C concentrate in newborns with severe congenital protein C deficiency. Semin Thromb Hemost. 1995;21:371-381.
62. Chuansumrit A, Isarangkura P, Hathirat P. Vitamin K deficiency bleeding in Thailand: a 32-year history. Southeast Asian J Trop Med Public Health. 1998;29:649-654.
63. Renzulli P, Tuchschmid P, Eich G, Fanconi S, Schwöbel MG. Early vitamin K deficiency bleeding after maternal phenobarbital intake: management of massive intracranial haemorrhage by minimal surgical intervention. Eur J Pediatr. 1998;157:663-665.
64. Sutor AH, von Kries R, Cornelissen EA, McNinch AW, Andrew M. Vitamin K deficiency bleeding (VKDB) in infancy. ISTH Pediatric/ Perinatal Subcommittee. International Society on Thrombosis and Hae-mostasis. Thromb Haemost. 1999;81:456-461.
65. Bottos M, Feliciangeli A, Sciuto L, Gericke C, Vianello A. Functional status of adults with cerebral palsy and implications for treatment of children. Dev Med Child Neurol. 2001;43:516-528.
66. Sala DA, Grant AD. Prognosis for ambulation in cerebral palsy. Dev Med Child Neurol. 1995;37:1020-1026.
67. Awaad Y, Tayem H, Munoz S, Ham S, Michon AM, Awaad R. Functional assessment following intrathecal baclofen therapy in children with spastic cerebral palsy. J Child Neurol. 2003;18:26 -34.
68. Reid DT. Benefits of a virtual play rehabilitation environment for children with cerebral palsy on perceptions of self-efficacy: a pilot study. Pediatr Rehabil. 2002;5:141-148.
69. Fedrizzi E, Pagliano E, Andreucci E, Oleari G. Hand function in children with hemiplegic cerebral palsy: prospective follow-up and functional outcome in adolescence. Dev Med Child Neurol. 2003;45: 85-91.
70. Majnemer A. Benefits of early intervention for children with developmental disabilities. Semin Pediatr Neurol. 1998;5:62- 69.
71. Taub E, Ramey SL, DeLuca S, Echols K. Efficacy of constraint-induced movement therapy for children with cerebral palsy with asymmetric motor impairment. Pediatrics. 2004;113:305-312.
72. Myles LM, Massicotte P, Drake J. Intracranial hemorrhage in neonates with unrecognized hemophilia A: a persisting problem. Pediatr Neurosurg. 2001;34:94-97.
73. Roach ES. Etiology of stroke in children. Semin Pediatr Neurol. 2000; 7:244-260.
74. Sträter R, Becker S, von Eckardstein A, Heinecke A, Gutsche S, Junker R, Kurnik K, Schobess R, Nowak-Göttl U. Prospective assessment of risk factors for recurrent stroke during childhood-a 5-year follow-up study. Lancet. 2002;360:1540-1545.
75. Ganesan V, Prengler M, Wade A, Kirkham FJ. Clinical and radiological recurrence after childhood arterial ischemic stroke. Circulation. 2006; 114:2170-2177.
76. Brower MC, Rollins N, Roach ES. Basal ganglia and thalamic infarction in children. Cause and clinical features. Arch Neurol. 1996;53: 1252-1256.
77. Prengler M, Pavlakis SG, Prohovnik I, Adams RJ. Sickle cell disease: the neurological complications. Ann Neurol. 2002;51:543-552.
78. Ohene-Frempong K, Weiner SJ, Sleeper LA, Miller ST, Embury S, Moohr JW, Wethers DL, Pegelow CH, Gill FM. Cerebrovascular accidents in sickle cell disease: rates and risk factors. Blood. 1998;91: 288-294.
79. Henderson JN, Noetzel MJ, McKinstry RC, White DA, Armstrong M, DeBaun MR. Reversible posterior leukoencephalopathy syndrome and silent cerebral infarcts are associated with severe acute chest syndrome in children with sickle cell disease. Blood. 2003;101:415- 419.
80. National Heart, Lung, and Blood Institute, National Institutes of Health. Clinical alert from the National Heart, Lung, and Blood Institute [press release]. September 18, 1997. Available at: http://www.nhlbi.nih.gov/ new/press/nhlb-18a.htm. Accessed June 15, 2008.
81. Adams R, McKie V, Nichols F, Carl E, Zhang DL, McKie K, Figueroa R, Litaker M, Thompson W, Hess D. The use of transcranial ultra-sonography to predict stroke in sickle cell disease. N Engl J Med. 1992;326:605-610.
82. Adams RJ, McKie VC, Hsu L, Files B, Vichinsky E, Pegelow C, Abboud M, Gallagher D, Kutlar A, Nichols FT, Bonds DR, Brambilla D. Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography. N Engl J Med. 1998;339:5-11.
83. Kwiatkowski JL, Granger S, Brambilla DJ, Brown RC, Miller ST, Adams RJ; Stop Trial Investigators. Elevated blood flow velocity in the anterior cerebral artery and stroke risk in sickle cell disease: extended analysis from the STOP trial. Br J Haematol. 2006;134:333-339.
84. Driscoll MC, Hurlet A, Styles L, McKie V, Files B, Olivieri N, Pegelow C, Berman B, Drachtman R, Patel K, Brambilla D. Stroke risk in siblings with sickle cell anemia. Blood. 2003;101:2401-2404.
85. Hoppe C, Klitz W, Cheng S, Apple R, Steiner L, Robles L, Girard T, Vichinsky E, Styles L; CSSCD Investigators. Gene interactions and stroke risk in children with sickle cell anemia. Blood. 2004;103: 2391-2396.
86. Sebastiani P, Ramoni MF, Nolan V, Baldwin CT, Steinberg MH. Genetic dissection and prognostic modeling of overt stroke in sickle cell anemia. Nat Genet. 2005;37:435-440.
87. Kirkham FJ, Hewes DK, Prengler M, Wade A, Lane R, Evans JP. Nocturnal hypoxaemia and central-nervous-system events in sickle-cell disease. Lancet. 2001;357:1656-1659.
88. Pegelow CH, Adams RJ, McKie V, Abboud M, Berman B, Miller ST, Olivieri N, Vichinsky E, Wang W, Brambilla D. Risk of recurrent stroke in patients with sickle cell disease treated with erythrocyte transfusions. J Pediatr. 1995;126:896-899.
89. Scothorn DJ, Price C, Schwartz D, Terrill C, Buchanan GR, Shurney W, Sarniak I, Fallon R, Chu JY, Pegelow CH, Wang W, Casella JF, Resar LS, Berman B, Adamkiewicz T, Hsu LL, Ohene-Frempong K, Smith-Whitley K, Mahoney D, Scott JP, Woods GM, Watanabe M, Debaun MR. Risk of recurrent stroke in children with sickle cell disease receiving blood transfusion therapy for at least five years after initial stroke. J Pediatr. 2002;140:348 -354.
90. Dobson SR, Holden KR, Nietert PJ, Cure JK, Laver JH, Disco D, Abboud MR. Moyamoya syndrome in childhood sickle cell disease: a predictive factor for recurrent cerebrovascular events. Blood. 2002;99: 3144-3150.
91. Moser FG, Miller ST, Bello JA, Pegelow CH, Zimmerman RA, Wang WC, Ohene-Frempong K, Schwartz A, Vichinsky EP, Gallagher D, Kinney TR. The spectrum of brain MR abnormalities in sickle-cell disease: a report from the Cooperative Study of Sickle Cell Disease. AJNR Am J Neuroradiol. 1996;17:965-972.
92. Armstrong FD, Thompson RJ Jr, Wang W, Zimmerman R, Pegelow CH, Miller S, Moser F, Bello J, Hurtig A, Vass K. Cognitive functioning and brain magnetic resonance imaging in children with sickle cell disease. Neuropsychology Committee of the Cooperative Study of Sickle Cell Disease. Pediatrics. 1996;97:864-870.
93. Miller ST, Macklin EA, Pegelow CH, Kinney TR, Sleeper LA, Bello JA, DeWitt LD, Gallagher DM, Guarini L, Moser FG, Ohene-Frempong K, Sanchez N, Vichinsky EP, Wang WC, Wethers DL, Younkin DP, Zimmerman RA, DeBaun MR; Cooperative Study of Sickle Cell Disease. Silent infarction as a risk factor for overt stroke in children with sickle cell anemia: a report from the Cooperative Study of Sickle Cell Disease. J Pediatr. 2001;139:385-390.
94. Strouse JJ, Hulbert ML, DeBaun MR, Jordan LC, Casella JF. Primary hemorrhagic stroke in children with sickle cell disease is associated with recent transfusion and use of corticosteroids. Pediatrics. 2006;118: 1916-1924.
95. Naran AD, Fontana L. Sickle cell disease with orbital infarction and epidural hematoma. Pediatr Radiol. 2001;31:257-259.
96. Mallouh AA, Hamdan JA. Intracranial hemorrhage in patients with sickle cell disease. Am J Dis Child. 1986;140:505-506.
97. National Heart, Lung, and Blood Institute, National Institutes of Health. The management of sickle cell disease. Available at: http:// www.nhlbi.nih.gov/health/prof/blood/sickle/sc-mngt.pdf. Accessed June 15, 2008.
98. Rothman SM, Fulling KH, Nelson JS. Sickle cell anemia and central nervous system infarction: a neuropathological study. Ann Neurol. 1986; 20:684-690.
99. Fullerton HJ, Adams RJ, Zhao S, Johnston SC. Declining stroke rates in Californian children with sickle cell disease. Blood. 2004;104:336-339.
100. National Heart, Lung, and Blood Institute, National Institutes of Health. Clinical alert from the National Heart, Lung, and Blood Institute [press release]. December 5, 2004. Available at: http://www.nhlbi.nih.gov/ health/prof/blood/sickle/clinical-alert-scd.htm. Accessed June 15, 2008.
101. Charache S, Terrin ML, Moore RD, Dover GJ, Barton FB, Eckert SV, McMahon RP, Bonds DR. Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia. N Engl J Med. 1995;332: 1317-1322.
102. Gulbis B, Haberman D, Dufour D, Christophe C, Vermylen C, Kagambega F, Corazza F, Devalck C, Dresse MF, Hunninck K, Klein A, Le PQ, Loop M, Maes P, Philippet P, Sariban E, Van Geet C, Ferster A. Hydroxyurea for sickle cell disease in children and for prevention of cerebrovascular events: the Belgian experience. Blood. 2005;105: 2685-2690.
103. Ware RE, Zimmerman SA, Sylvestre PB, Mortier NA, Davis JS, Treem WR, Schultz WH. Prevention of secondary stroke and resolution of transfusional iron overload in children with sickle cell anemia using hydroxyurea and phlebotomy. J Pediatr. 2004;145:346-352.
104. Walters MC, Storb R, Patience M, Leisenring W, Taylor T, Sanders JE, Buchanan GE, Rogers ZR, Dinndorf P, Davies SC, Roberts IA, Dick-erhoff R, Yeager AM, Hsu L, Kurtzberg J, Ohene-Frempong K, Bunin N, Bernaudin F, Wong WY, Scott JP, Margolis D, Vichinsky E, Wall DA, Wayne AS, Pegelow C, Redding-Lallinger R, Wiley J, Klemperer M, Mentzer WC, Smith FO, Sullivan KM. Impact of bone marrow transplantation for symptomatic sickle cell disease: an interim report. Multicenter investigation of bone marrow transplantation for sickle cell disease. Blood 2000;95:1918-1924.
105. Vernet O, Montes JL, O'Gorman AM, Baruchel S, Farmer JP. Encephaloduroarterio-synangiosis in a child with sickle cell anemia and moyamoya disease. Pediatr Neurol. 1996;14:226-230.
106. Fryer RH, Anderson RC, Chiriboga CA, Feldstein NA. Sickle cell anemia with moyamoya disease: outcomes after EDAS procedure. Pediatr Neurol. 2003;29:124-130.
107. Adams RJ, Brambilla DJ, Granger S, Gallagher D, Vichinsky E, Abboud MR, Pegelow CH, Woods G, Rohde EM, Nichols FT, Jones A, Luden JP, Bowman L, Hagner S, Morales KH, Roach ES; STOP Study. Stroke and conversion to high risk in children screened with transcranial Dopp-ler ultrasound during the STOP study. Blood. 2004;103:3689-3694.
108. Wang WC. The pathophysiology, prevention, and treatment of stroke in sickle cell disease. Curr Opin Hematol. 2007;14:191-197.
109. Uchino K, Johnston SC, Becker KJ, Tirschwell DL. Moyamoya disease in Washington State and California. Neurology. 2005;65:956-958.
110. Fung LW, Thompson D, Ganesan V. Revascularisation surgery for paediatric moyamoya: a review of the literature. Childs Nerv Syst. 2005;21:358-364.
111. Nagaraja D, Verma A, Taly AB, Kumar MV, Jayakumar PN. Cerebro-vascular disease in children. Acta Neurol Scand. 1994;90:251-255.
112. Soriano SG, Sethna NF, Scott RM. Anesthetic management of children with moyamoya syndrome. Anesth Analg. 1993;77:1066-1070.
113. Scott RM, Smith JL, Robertson RL, Madsen JR, Soriano SG, Rockoff MA. Long-term outcome in children with moyamoya syndrome after cranial revascularization by pial synangiosis. J Neurosurg. 2004;100(2 suppl Pediatrics):142-149.
114. Ohaegbulam C, Magge S, Scott RM. Moyamoya syndrome. In: McLone DG, ed. Pediatric Neurosurgery. Philadelphia, PA: WB Saunders; 2001: 1077-1092.
115. Suzuki J, Kodama N. Moyamoya disease-a review. Stroke. 1983;14: 104-109.
116. Caldarelli M, Di Rocco C, Gaglini P. Surgical treatment of moyamoya disease in pediatric age. J Neurosurg Sci. 2001;45:83-91.
117. Wakai K, Tamakoshi A, Ikezaki K, Fukui M, Kawamura T, Aoki R, Kojima M, Lin Y, Ohno Y. Epidemiological features of moyamoya disease in Japan: findings from a nationwide survey. Clin Neurol Neurosurg. 1997;99(suppl 2):S1-S5.
118. Yonekawa Y, Ogata N, Kaku Y, Taub E, Imhof HG. Moyamoya disease in Europe, past and present status. Clin Neurol Neurosurg. 1997; 99(suppl 2):S58-S60.
119. Han DH, Kwon OK, Byun BJ, Choi BY, Choi CW, Choi JU, Choi SG, Doh JO, Han JW, Jung S, Kang SD, Kim DJ, Kim HI, Kim HD, Kim MC, Kim SC, Kim SC, Kim Y, Kwun BD, Lee BG, Lim YJ, Moon JG, Park HS, Shin MS, Song JH, Suk JS, Yim MB; Korean Society for Cerebrovascular Disease. A co-operative study: clinical characteristics of 334 Korean patients with moyamoya disease treated at neurosurgical institutes (1976 -1994). The Korean Society for Cerebrovascular Disease. Acta Neurochir (Wien). 2000;142:1263-1273; discussion 1273-1274.
120. Yilmaz EY, Pritz MB, Bruno A, Lopez-Yunez A, Biller J. Moyamoya: Indiana University Medical Center experience. Arch Neurol. 2001;58: 1274-1278.
121. Kitahara T, Ariga N, Yamaura A, Makino H, Maki Y. Familial occurrence of moya-moya disease: report of three Japanese families. J Neurol Neurosurg Psychiatry. 1979;42:208-214.
122. Søgaard I, Jørgensen J. Familial occurrence of bilateral intracranial occlusion of the internal carotid arteries (Moya Moya). Acta Neurochir (Wien). 1975;31:245-252.
123. Hamada JI, Yoshioka S, Nakahara T, Marubayashi T, Ushio Y. Clinical features of moyamoya disease in sibling relations under 15 years of age. Acta Neurochir (Wien). 1998;140:455-458.
124. Ikeda H, Sasaki T, Yoshimoto T, Fukui M, Arinami T. Mapping of a familial moyamoya disease gene to chromosome 3p24.2-p26. Am J Hum Genet. 1999;64:533-537.
125. Nanba R, Tada M, Kuroda S, Houkin K, Iwasaki Y. Sequence analysis and bioinformatics analysis of chromosome 17q25 in familial moya-moya disease. Childs Nerv Syst. 2005;21:62-68.
126. Inoue TK, Ikezaki K, Sasazuki T, Matsushima T, Fukui M. Linkage analysis of moyamoya disease on chromosome 6. J Child Neurol. 2000;15:179-182.
127. Scott RM. Surgery for moyamoya syndrome? Yes. Arch Neurol. 2001; 58:128-129.
128. Kawai M, Nishikawa T, Tanaka M, Ando A, Kasajima T, Higa T, Tanikawa T, Kagawa M, Momma K. An autopsied case of Williams syndrome complicated by moyamoya disease. Acta Paediatr Jpn. 1993; 35:63-67.
129. Kaplan P, Levinson M, Kaplan BS. Cerebral artery stenoses in Williams syndrome cause strokes in childhood. J Pediatr. 1995;126:943-945.
130. Connor SE, Hewes D, Ball C, Jarosz JM. Alagille syndrome associated with angiographic moyamoya. Childs Nerv Syst. 2002;18:186-190.
131. Rachmel A, Zeharia A, Neuman-Levin M, Weitz R, Shamir R, Dinari G. Alagille syndrome associated with moyamoya disease. Am J Med Genet. 1989;33:89-91.
132. Choi JU, Kim DS, Kim EY, Lee KC. Natural history of moyamoya disease: comparison of activity of daily living in surgery and non surgery groups. Clin Neurol Neurosurg. 1997;99(suppl 2):S11-S18.
133. Ezura M, Yoshimoto T, Fujiwara S, Takahashi A, Shirane R, Mizoi K. Clinical and angiographic follow-up of childhood-onset moyamoya disease. Childs Nerv Syst. 1995;11:591-594.
134. Kurokawa T, Tomita S, Ueda K, Narazaki O, Hanai T, Hasuo K, Matsushima T, Kitamura K. Prognosis of occlusive disease of the circle of Willis (moyamoya disease) in children. Pediatr Neurol. 1985;1: 274-277.
135. Maki Y, Enomoto T. Moyamoya disease. Childs Nerv Syst. 1988;4: 204-212.
136. Fukuyama Y, Umezu R. Clinical and cerebral angiographic evolutions of idiopathic progressive occlusive disease of the circle of Willis ("moyamoya" disease) in children. Brain Dev. 1985;7:21-37.
137. Shin IS, Cheng R, Pordell GR. Striking CT scan findings in a case of unilateral moyamoya disease-a case report. Angiology. 1991;42: 665-671.
138. Fujita K, Shirakuni T, Kojima N, Tamaki N, Matsumoto S. [Magnetic resonance imaging in moyamoya disease]. No Shinkei Geka. 1986; 14(suppl):324-330.
139. Kirkham FJ, DeBaun MR. Stroke in children with sickle cell disease. Curr Treat Options Neurol. 2004;6:357-375.
140. Rosser TL, Vezina G, Packer RJ. Cerebrovascular abnormalities in a population of children with neurofibromatosis type 1. Neurology. 2005; 64:553-555.
141. Jea A, Smith ER, Robertson R, Scott RM. Moyamoya syndrome associated with Down syndrome: outcome after surgical revascularization. Pediatrics. 2005;116:e694-e701.
142. Chabbert V, Ranjeva JP, Sevely A, Boetto S, Berry I, Manelfe C. Diffusion- and magnetisation transfer-weighted MRI in childhood moya-moya. Neuroradiology. 1998;40:267-271.
143. Yamada I, Matsushima Y, Suzuki S. Moyamoya disease: diagnosis with three-dimensional time-of-flight MR angiography. Radiology. 1992; 184:773-778.
144. Sunaga Y, Fujinaga T, Ohtsuka T. [MRI findings of moyamoya disease in children]. No To Hattatsu. 1992;24:375-379.
145. Brady AP, Stack JP, Ennis JT. Moyamoya disease-imaging with magnetic resonance. Clin Radiol. 1990;42:138-141.
146. Rolak LA. Magnetic resonance imaging in moyamoya disease. Arch Neurol. 1989;46:14.
147. Bruno A, Yuh WT, Biller J, Adams HP Jr, Cornell SH. Magnetic resonance imaging in young adults with cerebral infarction due to moyamoya. Arch Neurol. 1988;45:303-306.
148. Yamada I, Suzuki S, Matsushima Y. Moyamoya disease: comparison of assessment with MR angiography and MR imaging versus conventional angiography. Radiology. 1995;196:211-218.
149. Yamada I, Matsushima Y, Suzuki S. Childhood moyamoya disease before and after encephalo-duro-arterio-synangiosis: an angiographic study. Neuroradiology. 1992;34:318-322.
150. Yamada I, Suzuki S, Matsushima Y. Moyamoya disease: diagnostic accuracy of MRI. Neuroradiology. 1995;37:356-361.
151. Katz DA, Marks MP, Napel SA, Bracci PM, Roberts SL. Circle of Willis: evaluation with spiral CT angiography, MR angiography, and conventional angiography. Radiology. 1995;195:445-449.
152. Takanashi JI, Sugita K, Niimi H. Evaluation of magnetic resonance angiography with selective maximum intensity projection in patients with childhood moyamoya disease. Eur J Paediatr Neurol. 1998;2: 83-89.
153. Chang KH, Yi JG, Han MH, Kim IO. MR imaging findings of moya-moya disease. J Korean Med Sci. 1990;5:85-90.
154. Robertson RL, Chavali RV, Robson CD, Barnes PD, Eldredge EA, Burrows PE, Scott RM. Neurologic complications of cerebral angiography in childhood moyamoya syndrome. Pediatr Radiol. 1998; 28:824-829.
155. Kim JH, Shin T, Park JH, Chung SH, Choi NC, Lim BH. Various patterns of perfusion-weighted MR imaging and MR angiographic findings in hyperacute ischemic stroke. AJNR Am J Neuroradiol. 1999; 20:613-620.
156. Seitz RJ, Meisel S, Weller P, Junghans U, Wittsack HJ, Siebler M. Initial ischemic event: perfusion-weighted MR imaging and apparent diffusion coefficient for stroke evolution. Radiology. 2005;237: 1020-1028.
157. Koga M, Reutens DC, Wright P, Phan T, Markus R, Pedreira B, Fitt G, Lim I, Donnan GA. The existence and evolution of diffusion-perfusion mismatched tissue in white and gray matter after acute stroke. Stroke. 2005;36:2132-2137.
158. Takase K, Kashihara M, Hashimoto T. Transcranial Doppler ultrasonography in patients with moyamoya disease. Clin Neurol Neurosurg. 1997;99(suppl 2):S101-S105.
159. Morgenstern C, Griewing B, Muller-Esch G, Zeller JA, Kessler C. Transcranial power-mode duplex ultrasound in two patients with moya-moya syndrome. J Neuroimaging. 1997;7:190-192.
160. Takeuchi S, Tanaka R, Ishii R, Tsuchida T, Kobayashi K, Arai H. Cerebral hemodynamics in patients with moyamoya disease. A study of regional cerebral blood flow by the 133Xe inhalation method. Surg Neurol. 1985;23:468-474.
161. Nambu K, Suzuki R, Hirakawa K. Cerebral blood flow: measurement with xenon-enhanced dynamic helical CT. Radiology. 1995;195:53-57.
162. Liu HM, Peng SS, Li YW. The preoperative and postoperative cerebral blood flow and vasoreactivity in childhood moyamoya disease. Keio J Med. 2000;49(suppl 1):A86-A89.
163. Shirane R, Yoshida Y, Takahashi T, Yoshimoto T. Assessment of encephalo-galeo-myo-synangiosis with dural pedicle insertion in childhood moyamoya disease: characteristics of cerebral blood flow and oxygen metabolism. Clin Neurol Neurosurg. 1997;99(suppl 2):S79-S85.
164. Khan N, Yonekawa Y. Moyamoya angiopathy in Europe. Acta Neurochir Suppl. 2005;94:149-152.
165. Tanaka Y, Nariai T, Nagaoka T, Akimoto H, Ishiwata K, Ishii K, Matsushima Y, Ohno K. Quantitative evaluation of cerebral hemodynamics in patients with moyamoya disease by dynamic susceptibility contrast magnetic resonance imaging-comparison with positron emission tomography. J Cereb Blood Flow Metab. 2006;26:291-300.
166. Ikezaki K, Matsushima T, Kuwabara Y, Suzuki SO, Nomura T, Fukui M. Cerebral circulation and oxygen metabolism in childhood moyamoya disease: a perioperative positron emission tomography study. J Neurosurg. 1994;81:843-850.
167. Fukui M. Guidelines for the diagnosis and treatment of spontaneous occlusion of the circle of Willis ('moyamoya' disease). Research Committee on Spontaneous Occlusion of the Circle of Willis (Moyamoya Disease) of the Ministry of Health and Welfare, Japan. Clin Neurol Neurosurg. 1997;99(suppl 2):S238-S240.
168. Kawano T, Fukui M, Hashimoto N, Yonekawa Y. Follow-up study of patients with "unilateral" moyamoya disease. Neurol Med Chir (Tokyo). 1994;34:744-747.
169. Ikezaki K. Rational approach to treatment of moyamoya disease in childhood. J Child Neurol. 2000;15:350-356.
170. Matsushima T, Inoue T, Ikezaki K, Matsukado K, Natori Y, Inamura T, Fukui M. Multiple combined indirect procedure for the surgical treatment of children with moyamoya disease. A comparison with single indirect anastomosis and direct anastomosis. Neurosurg Focus. 1998;5:e4.
171. Kawaguchi S, Okuno S, Sakaki T. Effect of direct arterial bypass on the prevention of future stroke in patients with the hemorrhagic variety of moyamoya disease. J Neurosurg. 2000;93:397-401.
172. Houkin K, Abe H, Yoshimoto T, Takahashi A. Is "unilateral" moyamoya disease different from moyamoya disease? J Neurosurg. 1996;85: 772-776.
173. Sencer S, Poyanli A, Kiris T, Sencer A, Minareci O. Recent experience with Moyamoya disease in Turkey. Eur Radiol. 2000;10:569-572.
174. Houkin K, Kuroda S, Nakayama N. Cerebral revascularization for moyamoya disease in children. Neurosurg Clin N Am. 2001;12:575-584.
175. Dauser RC, Tuite GF, McCluggage CW. Dural inversion procedure for moyamoya disease. Technical note. J Neurosurg. 1997;86:719-723.
176. Matsushima T, Inoue T, Katsuta T, Natori Y, Suzuki S, Ikezaki K, Fukui M. An indirect revascularization method in the surgical treatment of moyamoya disease: various kinds of indirect procedures and a multiple combined indirect procedure. Neurol Med Chir (Tokyo). 1998;38(suppl): 297-302.
177. Matsushima Y. [Indirect anastomoses for moyamoya disease]. No Shinkei Geka. 1998;26:769-786.
178. Nomura S, Kashiwagi S, Uetsuka S, Uchida T, Kubota H, Ito H. Perioperative management protocols for children with moyamoya disease. Childs Nerv Syst. 2001;17:270-274.
179. Fukui M. Current state of study on moyamoya disease in Japan. Surg Neurol. 1997;47:138-143.
180. Scott RM. Moyamoya syndrome: a surgically treatable cause of stroke in the pediatric patient. Clin Neurosurg. 2000;47:378 -384.
181. Bowen MD, Burak CR, Barron TF. Childhood ischemic stroke in a nonurban population. J Child Neurol. 2005;20:194-197.
182. Fullerton HJ, Johnston SC, Smith WS. Arterial dissection and stroke in children. Neurology. 2001;57:1155-1160.
183. Chabrier S, Lasjaunias P, Husson B, Landrieu P, Tardieu M. Ischaemic stroke from dissection of the craniocervical arteries in childhood: report of 12 patients. Eur J Paediatr Neurol. 2003;7:39-42.
184. Rafay MF, Armstrong D, Deveber G, Domi T, Chan A, MacGregor DL. Craniocervical arterial dissection in children: clinical and radiographic presentation and outcome. J Child Neurol. 2006;21:8-16.
185. Touzé E, Gauvrit JY, Moulin T, Meder JF, Bracard S, Mas JL; Multi-center Survey on Natural History of Cervical Artery Dissection. Risk of stroke and recurrent dissection after a cervical artery dissection: a multicenter study. Neurology. 2003;61:1347-1351.
186. Schievink WI. Spontaneous dissection of the carotid and vertebral arteries. N Engl J Med. 2001;344:898-906.
187. Sacco RL, Adams R, Albers G, Alberts MJ, Benavente O, Furie K, Goldstein LB, Gorelick P, Halperin J, Harbaugh R, Johnston SC, Katzan I, Kelly-Hayes M, Kenton EJ, Marks M, Schwamm LH, Tomsick T; American Heart Association; American Stroke Association Council on Stroke; Council on Cardiovascular Radiology and Intervention; American Academy of Neurology. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/ American Stroke Association Council on Stroke. Stroke. 2006;37: 577-617.
188. Pearl PL. Childhood stroke following intraoral trauma. J Pediatr. 1987; 110:574-575.
189. Woodhurst WB, Robertson WD, Thompson GB. Carotid injury due to intraoral trauma: case report and review of the literature. Neurosurgery. 1980;6:559-563.
190. Graham CJ, Schwartz JE, Stacy T. Stroke following oral trauma in children. Ann Emerg Med. 1991;20:1029-1031.
191. Sébire G, Meyer L, Chabrier S. Varicella as a risk factor for cerebral infarction in childhood: a case-control study. Ann Neurol. 1999;45: 679-680.
192. Askalan R, Laughlin S, Mayank S, Chan A, MacGregor D, Andrew M, Curtis R, Meaney B, deVeber G. Chickenpox and stroke in childhood: a study of frequency and causation. Stroke. 2001;32:1257-1262.
193. Benseler SM, deVeber G, Hawkins C, Schneider R, Tyrrell PN, Aviv RI, Armstrong D, Laxer RM, Silverman ED. Angiography-negative primary central nervous system vasculitis in children: a newly recognized inflammatory central nervous system disease. Arthritis Rheum. 2005;52: 2159-2167.
194. Danchaivijitr N, Cox TC, Saunders DE, Ganesan V. Evolution of cerebral arteriopathies in childhood arterial ischemic stroke. Ann Neurol. 2006;59:620-626.
195. Benseler SM, Silverman E, Aviv RI, Schneider R, Armstrong D, Tyrrell PN, deVeber G. Primary central nervous system vasculitis in children. Arthritis Rheum. 2006;54:1291-1297.
196. Kirkham F. Improvement or progression in childhood cerebral arte-riopathies: current difficulties in prediction and suggestions for research. Ann Neurol. 2006;59:580-582.
197. Sébire G, Fullerton H, Riou E, deVeber G. Toward the definition of cerebral arteriopathies of childhood. Curr Opin Pediatr. 2004;16: 617-622.
198. Sébire G. Transient cerebral arteriopathy in childhood. Lancet. 2006; 368:8-10.
199. Ebinger F, Boor R, Gawehn J, Reitter B. Ischemic stroke and migraine in childhood: coincidence or causal relation? J Child Neurol. 1999;14: 451-455.
200. Tzourio C, Benslamia L, Guillon B, Aidi S, Bertrand M, Berthet K, Bousser MG. Migraine and the risk of cervical artery dissection: a case-control study. Neurology. 2002;59:435-437.
201. van de Ven RC, Kaja S, Plomp JJ, Frants RR, van den Maagdenberg AM, Ferrari MD. Genetic models of migraine. Arch Neurol. 2007;64: 643-646.
202. Jen JC, Klein A, Boltshauser E, Cartwright MS, Roach ES, Mamsa H, Baloh RW. Prolonged hemiplegic episodes in children due to mutations in ATP1A2. J Neurol Neurosurg Psychiatry. 2007;78:523-526.
203. Pakalnis A. Current therapies in childhood and adolescent migraine. J Child Neurol. 2007;22:1288-1292.
204. Silberstein SD, Dodick D, Freitag F, Pearlman SH, Hahn SR, Scher AI, Lipton RB. Pharmacological approaches to managing migraine and associated comorbidities-clinical considerations for monotherapy versus polytherapy. Headache. 2007;47:585-599.
205. Kumar K. Neurological complications of congenital heart disease. Indian J Pediatr. 2000;67:287-291.
206. Jonas RA. Neurological protection during cardiopulmonary bypass/deep hypothermia. Pediatr Cardiol. 1998;19:321-330.
207. Cottrill CM, Kaplan S. Cerebral vascular accidents in cyanotic congenital heart disease. Am J Dis Child. 1973;125:484-487.
208. Phornphutkul C, Rosenthal A, Nadas AS, Berenberg W. Cerebro-vascular accidents in infants and children with cyanotic congenital heart disease. Am J Cardiol. 1973;32:329-334.
209. Agnetti A, Carano N, Sani E, Tchana B, Allegri V, Bernasconi S, Squarcia U. Cryptogenic stroke in children: possible role of patent foramen ovale. Neuropediatrics. 2006;37:53-56.
210. Kerut EK, Norfleet WT, Plotnick GD, Giles TD. Patent foramen ovale: a review of associated conditions and the impact of physiological size. J Am Coll Cardiol. 2001;38:613-623.
211. Bartz PJ, Cetta F, Cabalka AK, Reeder GS, Squarcia U, Agnetti A, Aurier E, Carano N, Tachana B, Hagler DJ. Paradoxical emboli in children and young adults: role of atrial septal defect and patent foramen ovale device closure. Mayo Clin Proc. 2006;81:615-618.
212. Braun MU, Fassbender D, Schoen SP, Haass M, Schraeder R, Scholtz W, Strasser RH. Transcatheter closure of patent foramen ovale in patients with cerebral ischemia. J Am Coll Cardiol. 2002;39: 2019-2025.
213. Hung J, Landzberg MJ, Jenkins KJ, King ME, Lock JE, Palacios IF, Lang P. Closure of patent foramen ovale for paradoxical emboli: intermediate-term risk of recurrent neurological events following trans-catheter device placement. J Am Coll Cardiol. 2000;35:1311-1316.
214. Butany J, Nair V, Naseemuddin A, Nair GM, Catton C, Yau T. Cardiac tumours: diagnosis and management. Lancet Oncol. 2005;6:219-228.
215. Wilson W, Taubert KA, Gewitz M, Lockhart PB, Baddour LM, Levison M, Bolger A, Cabell CH, Takahashi M, Baltimore RS, Newburger JW, Strom BL, Tani LY, Gerber M, Bonow RO, Pallasch T, Shulman ST, Rowley AH, Burns JC, Ferrieri P, Gardner T, Goff D, Durack DT; American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee; American Heart Association Council on Cardiovascular Disease in the Young; American Heart Association Council on Clinical Cardiology; American Heart Association Council on Cardiovascular Surgery and Anesthesia; Quality of Care and Outcomes Research Interdisciplinary Working Group. Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation. 2007;116:1736-1754.
216. Barnes C, Deveber G. Prothrombotic abnormalities in childhood ischaemic stroke. Thromb Res. 2006;118:67-74.
217. Lanthier S, Kirkham FJ, Mitchell LG, Laxer RM, Atenafu E, Male C, Prengler M, Domi T, Chan AK, Liesner R, deVeber G. Increased anticardiolipin antibody IgG titers do not predict recurrent stroke or TIA in children. Neurology. 2004;62:194-200.
218. Lockshin MD, Erkan D. Treatment of the antiphospholipid syndrome. N Engl J Med. 2003;349:1177-1179.
219. Bale JF Jr, Brasher C, Siegler RL. CNS manifestations of the hemolyticuremic syndrome. Relationship to metabolic alterations and prognosis. Am J Dis Child. 1980;134:869-872.
220. Crisp DE, Siegler RL, Bale JF, Thompson JA. Hemorrhagic cerebral infarction in the hemolytic-uremic syndrome. J Pediatr. 1981;99: 273-276.
221. Cardo E, Campistol J, Caritg J, Ruiz S, Vilaseca MA, Kirkham F, Blom HJ. Fatal haemorrhagic infarct in an infant with homocystinuria. Dev Med Child Neurol. 1999;41:132-135.
222. van Beynum IM, Smeitink JA, den Heijer M, te Poele Pothoff MT, Blom HJ. Hyperhomocysteinemia: a risk factor for ischemic stroke in children. Circulation. 1999;99:2070-2072.
223. Prengler M, Sturt N, Krywawych S, Surtees R, Liesner R, Kirkham F. Homozygous thermolabile variant of the methylenetetrahydrofolate reductase gene: a potential risk factor for hyperhomocysteinaemia, CVD, and stroke in childhood. Dev Med Child Neurol. 2001;43: 220-225.
224. Mudd SH, Skovby F, Levy HL, Pettigrew KD, Wilcken B, Pyeritz RE, Andria G, Boers GHJ, Bromberg IL, Cerone R, Fowler B, Gröbe H, Schmidt H, Schweitzer L. The natural history of homocystinuria due to cystathionine beta-synthase deficiency. Am J Hum Genet. 1985;37:1-31.
225. Wilcken DE, Wilcken B, Dudman NP, Tyrrell PA. Homocystinuria-the effects of betaine in the treatment of patients not responsive to pyri-doxine. N Engl J Med. 1983;309:448-453.
226. Toole JF, Malinow MR, Chambless LE, Spence JD, Pettigrew LC, Howard VJ, Sides EG, Wang CH, Stampfer M. Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial. JAMA. 2004;291:565-575.
227. Lidegaard Ø, Kreiner S. Contraceptives and cerebral thrombosis: a five-year national case-control study. Contraception. 2002;65:197-205.
228. Lidegaard O. Oral contraception and risk of a cerebral thromboembolic attack: results of a case-control study. BMJ. 1993;306:956 -963.
229. Lidegaard O. Smoking and use of oral contraceptives: impact on thrombotic diseases. Am J Obstet Gynecol. 1999;180:S357-S363.
230. Koga Y, Akita Y, Junko N, Yatsuga S, Povalko N, Fukiyama R, Ishii M, Matsuishi T. Endothelial dysfunction in MELAS improved by L-arginine supplementation. Neurology. 2006;66:1766-1769.
231. Rolfs A, Böttcher T, Zschiesche M, Morris P, Winchester B, Bauer P, Walter U, Mix E, Löhr M, Harzer K, Strauss U, Pahnke J, Grossmann A, Benecke R. Prevalence of Fabry disease in patients with cryptogenic stroke: a prospective study. Lancet. 2005;366:1794-1796.
232. Brouns R, Sheorajpanday R, Braxel E, Eyskens F, Baker R, Hughes D, Mehta A, Timmerman T, Vincent MF, De Deyn PP. Middelheim Fabry Study (MiFaS): a retrospective Belgian study on the prevalence of Fabry disease in young patients with cryptogenic stroke. Clin Neurol Neurosurg. 2007;109:479-484.
233. Eng CM, Guffon N, Wilcox WR, Germain DP, Lee P, Waldek S, Caplan L, Linthorst GE, Desnick RJ; International Collaborative Fabry Disease Study Group. Safety and efficacy of recombinant human alpha-galactosidase A-replacement therapy in Fabry's disease. N Engl J Med. 2001;345:9-16.
234. Eng CM, Germain DP, Banikazemi M, Warnock DG, Wanner C, Hopkin RJ, Bultas J, Lee P, Sims K, Brodie SE, Pastores GM, Strotmann JM, Wilcox WR. Fabry disease: guidelines for the evaluation and management of multi-organ system involvement. Genet Med. 2006;8: 539-548.
235. Xu MS, Tan CB, Umapathi T, Lim CC. Susac syndrome: serial diffusion-weighted MR imaging. Magn Reson Imaging. 2004;22: 1295-1298.
236. Susac JO, Murtagh FR, Egan RA, Berger JR, Bakshi R, Lincoff N, Gean AD, Galetta SL, Fox RJ, Costello FE, Lee AG, Clark J, Layzer RB, Daroff RB. MRI findings in Susac's syndrome. Neurology. 2003;61: 1783-1787.
237. Fox RJ, Costello F, Judkins AR, Galetta SL, Maguire AM, Leonard B, Markowitz CE. Treatment of Susac syndrome with gamma globulin and corticosteroids. J Neurol Sci. 2006;251:17-22.
238. Flammer J, Kaiser H, Haufschild T. Susac syndrome: a vasospastic disorder? Eur J Ophthalmol. 2001;11:175-179.
239. Joutel A, Vahedi K, Corpechot C, Troesch A, Chabriat H, Vayssiere C, Cruaud C, Maciazek J, Weissenbach J, Bousser MG, Bach JF, Tournier-Lasserve E. Strong clustering and stereotyped nature of Notch3 mutations in CADASIL patients. Lancet. 1997;350:1511-1515.
240. Golomb MR, Sokol DK, Walsh LE, Christensen CK, Garg BP. Recurrent hemiplegia, normal MRI, and NOTCH3 mutation in a 14-year-old: is this early CADASIL? Neurology. 2004;62:2331-2332.
241. Chabriat H, Vahedi K, Iba-Zizen MT, Joutel A, Nibbio A, Nagy TG, Krebs MO, Julien J, Dubois B, Ducrocq X, Levasseur M, Homeyer P, Mas JL, Lyon-Caen O, Tournier-Lasserve E, Bousser MG. Clinical spectrum of CADASIL: a study of 7 families. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencepha-lopathy. Lancet. 1995;346:934-939.
242. Dichgans M, Mayer M, Uttner I, Brüning R, Müller-Höcker J, Rungger G, Ebke M, Klockgether T, Gasser T. The phenotypic spectrum of CADASIL: clinical findings in 102 cases. Ann Neurol. 1998;44: 731-739.
243. Morgenstern LB, Viscoli CM, Kernan WN, Brass LM, Broderick JP, Feldmann E, Wilterdink JL, Brott T, Horwitz RI. Use of Ephedra-containing products and risk for hemorrhagic stroke. Neurology. 2003; 60:132-135.
244. Kernan WN, Viscoli CM, Brass LM, Broderick JP, Brott T, Feldmann E, Morgenstern LB, Wilterdink JL, Horwitz RI. Phenylpropanolamine and the risk of hemorrhagic stroke. N Engl J Med. 2000;343:1826-1832.
245. Jen J, Cohen AH, Yue Q, Stout JT, Vinters HV, Nelson S, Baloh RW. Hereditary endotheliopathy with retinopathy, nephropathy, and stroke (HERNS). Neurology. 1997;49:1322-1330.
246. Razvi SS, Bone I. Single gene disorders causing ischaemic stroke. J Neurol. 2006;253:685-700.
247. Lanska MJ, Lanska DJ, Horwitz SJ, Aram DM. Presentation, clinical course, and outcome of childhood stroke. Pediatr Neurol. 1991;7: 333-341.
248. Higgins JJ, Kammerman LA, Fitz CR. Predictors of survival and characteristics of childhood stroke. Neuropediatrics. 1991;22:190 -193.
249. Keidan I, Shahar E, Barzilay Z, Passwell J, Brand N. Predictors of outcome of stroke in infants and children based on clinical data and radiologic correlates. Acta Paediatr. 1994;83:762-765.
250. Eeg-Olofsson O, Ringheim Y. Stroke in children. Clinical characteristics and prognosis. Acta Paediatr Scand. 1983;72:391-395.
251. Lanthier S, Carmant L, David M, Larbrisseau A, de Veber G. Stroke in children: the coexistence of multiple risk factors predicts poor outcome. Neurology. 2000;54:371-378.
252. Blom I, De Schryver EL, Kappelle LJ, Rinkel GJ, Jennekens-Schinkel A, Peters AC. Prognosis of haemorrhagic stroke in childhood: a long-term follow-up study. Dev Med Child Neurol. 2003;45:233-239.
253. Lee MC, Frank JI, Kahana M, Tonsgard JH, Frim DM. Decompressive hemicraniectomy in a 6-year-old male after unilateral hemispheric stroke. Case report and review. Pediatr Neurosurg. 2003;38:181-185.
254. Chabrier S, Husson B, Lasjaunias P, Landrieu P, Tardieu M. Stroke in childhood: outcome and recurrence risk by mechanism in 59 patients. J Child Neurol. 2000;15:290-294.
255. Ganesan V, Hogan A, Shack N, Gordon A, Isaacs E, Kirkham FJ. Outcome after ischaemic stroke in childhood. Dev Med Child Neurol. 2000;42:455-461.
256. Pavlovic J, Kaufmann F, Boltshauser E, Capone Mori A, Gubser Mercati D, Haenggeli CA, Keller E, Lutschg J, Marcoz JP, Ramelli GP, Roulet Perez E, Schmitt-Mechelke T, Weissert M, Steinlin M. Neuro-psychological problems after paediatric stroke: two year follow-up of Swiss children. Neuropediatrics. 2006;37:13-19.
257. Salih MA, Abdel-Gader AG, Al-Jarallah AA, Kentab AY, Al-Nasser MN. Outcome of stroke in Saudi children. Saudi Med J. 2006;27(suppl 1):S91-S96.
258. De Schryver EL, Blom I, Braun KP, Kappelle LJ, Rinkel GJ, Peters AC, Jennekens-Schinkel A. Long-term prognosis of cerebral venous sinus thrombosis in childhood. Dev Med Child Neurol. 2004;46:514-519.
259. Ganesan V, Chong WK, Cox TC, Chawda SJ, Prengler M, Kirkham FJ. Posterior circulation stroke in childhood: risk factors and recurrence. Neurology. 2002;59:1552-1556.
260. Hogan AM, Kirkham FJ, Isaacs EB. Intelligence after stroke in childhood: review of the literature and suggestions for future research. J Child Neurol. 2000;15:325-332.
261. Max JE, Mathews K, Manes FF, Robertson BA, Fox PT, Lancaster JL, Lansing AE, Schatz A, Collings N. Attention deficit hyperactivity disorder and neurocognitive correlates after childhood stroke. J Int Neuropsychol Soc. 2003;9:815-829.
262. Max JE, Mathews K, Lansing AE, Robertson BA, Fox PT, Lancaster JL, Manes FF, Smith J. Psychiatric disorders after childhood stroke. J Am Acad Child Adolesc Psychiatry. 2002;41:555-562.
263. Friefeld S, Yeboah O, Jones JE, deVeber G. Health-related quality of life and its relationship to neurological outcome in child survivors of stroke. CNS Spectr. 2004;9:465-475.
264. Delsing BJ, Catsman-Berrevoets CE, Appel IM. Early prognostic indicators of outcome in ischemic childhood stroke. Pediatr Neurol. 2001; 24:283-289.
265. Ganesan V, Ng V, Chong WK, Kirkham FJ, Connelly A. Lesion volume, lesion location, and outcome after middle cerebral artery territory stroke. Arch Dis Child. 1999;81:295-300.
266. Boardman JP, Ganesan V, Rutherford MA, Saunders DE, Mercuri E, Cowan F. Magnetic resonance image correlates of hemiparesis after neonatal and childhood middle cerebral artery stroke. Pediatrics. 2005; 115:321-326.
267. Hurvitz EA, Beale L, Ried S, Nelson VS. Functional outcome of pae-diatric stroke survivors. Pediatr Rehabil. 1999;3:43-51.
268. Imaizumi T, Hayashi K, Saito K, Osawa M, Fukuyama Y. Long-term outcomes of pediatric moyamoya disease monitored to adulthood. Pediatr Neurol. 1998;18:321-325.
269. Hogan AM, Kirkham FJ, Isaacs EB, Wade AM, Vargha-Khadem F. Intellectual decline in children with moyamoya and sickle cell anaemia. Dev Med Child Neurol. 2005;47:824-829.
270. Paediatric Stroke Working Group, Royal College of Physicians of London. Stroke in childhood: clinical guidelines for diagnosis management and rehabilitation. Available at: http://www.rcplondon.ac.uk/ pubs/books/ childstroke/childstroke-guidelines.pdf. Accessed June 15, 2008.
271. Willis JK, Morello A, Davie A, Rice JC, Bennett JT. Forced use treatment of childhood hemiparesis. Pediatrics. 2002;110:94 -96.
272. Charles JR, Wolf SL, Schneider JA, Gordon AM. Efficacy of a child-friendly form of constraint-induced movement therapy in hemiplegic cerebral palsy: a randomized control trial. Dev Med Child Neurol. 2006;48:635-642.
273. Broderick J, Connolly S, Feldmann E, Hanley D, Kase C, Krieger D, Mayberg M, Morgenstern L, Ogilvy CS, Vespa P, Zuccarello M; American Heart Association; American Stroke Association Stroke Council; High Blood Pressure Research Council; Quality of Care and Outcomes in Research Interdisciplinary Working Group. Guidelines for the management of spontaneous intracerebral hemorrhage in adults: 2007 update: a guideline from the American Heart Association/ American Stroke Association Stroke Council, High Blood Pressure Research Council, and the Quality of Care and Outcomes in Research Interdisciplinary Working Group. Stroke. 2007;38:2001-2023.
274. Al-Jarallah A, Al-Rifai MT, Riela AR, Roach ES. Nontraumatic brain hemorrhage in children: etiology and presentation. J Child Neurol. 2000;15:284-289.
275. Meyer-Heim AD, Boltshauser E. Spontaneous intracranial haemorrhage in children: aetiology, presentation and outcome. Brain Dev. 2003;25: 416-421.
276. Jones BV, Ball WS, Tomsick TA, Millard J, Crone KR. Vein of Galen aneurysmal malformation: diagnosis and treatment of 13 children with extended clinical follow-up. AJNR Am J Neuroradiol. 2002;23: 1717-1724.
277. Van Hoff J, Ritchey AK, Shaywitz BA. Intracranial hemorrhage in children with sickle cell disease. Am J Dis Child. 1985;139:1120-1123.
278. Ghosh K, Nair AP, Jijina F, Madkaikar M, Shetty S, Mohanty D. Intracranial haemorrhage in severe haemophilia: prevalence and outcome in a developing country. Haemophilia. 2005;11:459-462.
279. Hoyer LW. Hemophilia A. N Engl J Med. 1994;330:38-47.
280. Eyster ME, Gill FM, Blatt PM, Hilgartner MW, Ballard JO, Kinney TR. Central nervous system bleeding in hemophiliacs. Blood. 1978;51: 1179-1188.
281. Andes WA, Wulff K, Smith WB. Head trauma in hemophilia. A prospective study. Arch Intern Med. 1984;144:1981-1983.
282. Baehner RL, Strauss HS. Hemophilia in the first year of life. N Engl J Med. 1966;275:524-528.
283. Lütschg J, Vassella F. Neurological complications in hemophilia. Acta Paediatr Scand. 1981;70:235-241.
284. de Tezanos Pinto M, Fernandez J, Perez Bianco PR. Update of 156 episodes of central nervous system bleeding in hemophiliacs. Haemostasis. 1992;22:259-267.
285. McCormick WF, Rosenfield DB. Massive brain hemorrhage: a review of 144 cases and an examination of their causes. Stroke. 1973;4: 946-954.
286. Patel AN, Richardson AE. Ruptured intracranial aneurysms in the first two decades of life. A study of 58 patients. J Neurosurg. 1971;35: 571-576.
287. Orozco M, Trigueros F, Quintana F, Dierssen G. Intracranial aneurysms in early childhood. Surg Neurol. 1978;9:247-252.
288. Lee YJ, Kandall SR, Ghali VS. Intracerebral arterial aneurysm in a newborn. Arch Neurol. 1978;35:171-172.
289. Newcomb AL, Munns GF. Rupture of aneurysm of the circle of Willis in the newborn. Pediatrics. 1949;3:769-772.
290. Sanai N, Quinones-Hinojosa A, Gupta NM, Perry V, Sun PP, Wilson CB, Lawton MT. Pediatric intracranial aneurysms: durability of treatment following microsurgical and endovascular management. J Neurosurg. 2006;104(2 suppl):82-89.
291. Buis DR, van Ouwerkerk WJ, Takahata H, Vandertop WP. Intracranial aneurysms in children under 1 year of age: a systematic review of the literature. Childs Nerv Syst. 2006;22:1395-1409.
292. Huang J, McGirt MJ, Gailloud P, Tamargo RJ. Intracranial aneurysms in the pediatric population: case series and literature review. Surg Neurol. 2005;63:424-432; discussion 432-433.
293. Proust F, Toussaint P, Garniéri J, Hannequin D, Legars D, Houtteville JP, Fréger P. Pediatric cerebral aneurysms. J Neurosurg. 2001;94: 733-739.
294. Shucart WA, Wolpert SM. Intracranial arterial aneurysms in childhood. Am J Dis Child. 1974;127:288-293.
295. Broderick JP, Viscoli CM, Brott T, Kernan WN, Brass LM, Feldmann E, Morgenstern LB, Wilterdink JL, Horwitz RI; Hemorrhagic Stroke Project Investigators. Major risk factors for aneurysmal subarachnoid hemorrhage in the young are modifiable. Stroke. 2003;34:1375-1381.
296. Koskinen LO, Blomstedt PC. Smoking and non-smoking tobacco as risk factors in subarachnoid haemorrhage. Acta Neurol Scand. 2006;114: 33-37.
297. Tyler HR, Clark DB. Neurologic complications in patients with coarc-tation of aorta. Neurology. 1958;8:712-718.
298. Dalgaard OZ. Bilateral polycystic disease of the kidneys; a follow-up of two hundred and eighty-four patients and their families. Acta Med Scand Suppl. 1957;328:1-255.
299. Chapman AB, Rubinstein D, Hughes R, Stears JC, Earnest MP, Johnson AM, Gabow PA, Kaehny WD. Intracranial aneurysms in autosomal dominant polycystic kidney disease. N Engl J Med. 1992;327:916-920.
300. Forster FM, Alpers BJ. Aneurysm of circle of Willis associated with congenital polycystic disease of the kidneys. Arch Neurol Psychiatry. 1943;50:669-676.
301. Mettinger KL, Ericson K. Fibromuscular dysplasia and the brain. I. Observations on angiographic, clinical and genetic characteristics. Stroke. 1982;13:46-52.
302. Sandok BA, Houser OW, Baker WL Jr, Holley KE. Fibromuscular dysplasia. Neurologic disorders associated with disease involving the great vessels in the neck. Arch Neurol. 1971;24:462-466.
303. Osborn AG, Anderson RE. Angiographic spectrum of cervical and intracranial fibromuscular dysplasia. Stroke. 1977;8:617- 626.
304. Beighton P. The Ehlers-Danlos syndromes. In: McKusick VA, Beighton P, eds. Heritable Disorders of Connective Tissue. 5th ed. St Louis, MO: Mosby-Year Book, Inc; 1993:189-251.
305. Krog M, Almgren B, Eriksson I, Nordström S. Vascular complications in the Ehlers-Danlos syndrome. Acta Chir Scand. 1983;149:279-282.
306. Pearl W, Spicer M. Ehlers-Danlos syndrome. South Med J. 1981;74: 80-81.
307. Munyer TP, Margulis AR. Pseudoxanthoma elasticum with internal carotid artery aneurysm. AJR Am J Roentgenol. 1981;136:1023-1024.
308. Hainsworth PJ, Mendelow AD. Giant intracranial aneurysm associated with Marfan's syndrome: a case report. J Neurol Neurosurg Psychiatry. 1991;54:471-472.
309. Matsuda M, Matsuda I, Handa H, Okamoto K. Intracavernous giant aneurysm associated with Marfan's syndrome. Surg Neurol. 1979;12: 119-121.
310. Finney LH, Roberts TS, Anderson RE. Giant intracranial aneurysm associated with Marfan's syndrome. Case report. J Neurosurg. 1976;45: 342-347.
311. ter Berg HW, Bijlsma JB, Veiga Pires JA, Ludwig JW, van der Heiden C, Tulleken CA, Willemse J. Familial association of intracranial aneu-rysms and multiple congenital anomalies. Arch Neurol. 1986;43:30-33.
312. ter Berg HW, Dippel DW, Limburg M, Schievink WI, van Gijn J. Familial intracranial aneurysms. A review. Stroke. 1992;23:1024-1030.
313. Morooka Y, Waga S. Familial intracranial aneurysms: report of four families. Surg Neurol. 1983;19:260-262.
314. Nagae K, Goto I, Ueda K, Morotomi Y. Familial occurrence of multiple intracranial aneurysms. Case report. J Neurosurg. 1972;37:364-367.
315. Andrews RJ. Intracranial aneurysms: characteristics of aneurysms in siblings. N Engl J Med. 1977;297:115.
316. Schievink WI, Schaid DJ, Rogers HM, Piepgras DG, Michels VV. On the inheritance of intracranial aneurysms. Stroke. 1994;25:2028 -2037.
317. Acosta-Rua GJ. Familial incidence of ruptured intracranial aneurysms. Report of 12 cases. Arch Neurol. 1978;35:675-677.
318. Lozano AM, Leblanc R. Familial intracranial aneurysms. J Neurosurg. 1987;66:522-528.
319. Alberts MJ, Quinones A, Graffagnino C, Friedman A, Roses AD. Risk of intracranial aneurysms in families with subarachnoid hemorrhage. Can J Neurol Sci. 1995;22:121-125.
320. ter Berg HW, Bijlsma JB, Willemse J. Familial occurrence of intra-cranial aneurysms in childhood: a case report and review of the literature. Neuropediatrics. 1987;18:227-230.
321. Raaymakers TW. Aneurysms in relatives of patients with subarachnoid hemorrhage: frequency and risk factors. MARS Study Group. Magnetic Resonance Angiography in Relatives of patients with Subarachnoid hemorrhage. Neurology. 1999;53:982-988.
322. Ronkainen A, Hernesniemi J, Puranen M, Niemitukia L, Vanninen R, Ryynänen M, Kuivaniemi H, Tromp G. Familial intracranial aneurysms. Lancet. 1997;349:380-384.
323. Wills S, Ronkainen A, van der Voet M, Kuivaniemi H, Helin K, Leinonen E, Frösen J, Niemela M, Jääskeläinen J, Hernesniemi J, Tromp G. Familial intracranial aneurysms: an analysis of 346 multiplex Finnish families. Stroke. 2003;34:1370 -1374.
324. van der Voet M, Olson JM, Kuivaniemi H, Dudek DM, Skunca M, Ronkainen A, Niemelä M, Jääskeläinen J, Hernesniemi J, Helin K, Leinonen E, Biswas M, Tromp G. Intracranial aneurysms in Finnish families: confirmation of linkage and refinement of the interval to chromosome 19q13.3. Am J Hum Genet. 2004;74:564-571.
325. Onda H, Kasuya H, Yoneyama T, Takakura K, Hori T, Takeda J, Nakajima T, Inoue I. Genomewide-linkage and haplotype-association studies map intracranial aneurysm to chromosome 7q11. Am J Hum Genet. 2001;69:804-819.
326. Ross JS, Masaryk TJ, Modic MT, Ruggieri PM, Haacke EM, Selman WR. Intracranial aneurysms: evaluation by MR angiography. AJR Am J Roentgenol. 1990;155:159-165.
327. Takeshita M, Kagawa M, Kubo O, Yato S, Satoh K, Ujiie H, Kasuya H, Izawa M. Clinicopathological study of bacterial intracranial aneurysms. Neurol Med Chir (Tokyo). 1991;31:508-513.
328. Bell WE, Butler C 2nd. Cerebral mycotic aneurysms in children. Two case reports. Neurology. 1968;18:81-86.
329. Ahuja GK, Jain N, Vijayaraghavan M, Roy S. Cerebral mycotic aneu-rysm of fungal origin. Case report. J Neurosurg. 1978;49:107-110.
330. Barrow DL, Prats AR. Infectious intracranial aneurysms: comparison of groups with and without endocarditis. Neurosurgery. 1990;27:562-572; discussion 572-573.
331. Morriss FH Jr, Spock A. Intracranial aneurysm secondary to mycotic orbital and sinus infection: report of a case implicating penicillium as an opportunistic fungus. Am J Dis Child. 1970;119:357-362.
332. Heidelberger KP, Layton WM Jr, Fisher RG. Multiple cerebral mycotic aneurysms complicating posttraumatic pseudomonas meningitis. Case report. J Neurosurg. 1968;29:631-635.
333. Husson RN, Saini R, Lewis LL, Butler KM, Patronas N, Pizzo PA. Cerebral artery aneurysms in children infected with human immunodeficiency virus. J Pediatr. 1992;121:927-930.
334. Agid R, Souza MP, Reintamm G, Armstrong D, Dirks P, TerBrugge KG. The role of endovascular treatment for pediatric aneurysms. Childs Nerv Syst. 2005;21:1030-1036.
335. Naff NJ, Wemmer J, Hoenig-Rigamonti K, Rigamonti DR. A longitudinal study of patients with venous malformations: documentation of a negligible hemorrhage risk and benign natural history. Neurology. 1998;50:1709-1714.
336. Stapf C, Mast H, Sciacca RR, Berenstein A, Nelson PK, Gobin YP, Pile-Spellman J, Mohr JP; New York Islands AVM Study Collaborators. The New York Islands AVM Study: design, study progress, and initial results. Stroke. 2003;34:e29-e33.
337. ApSimon HT, Reef H, Phadke RV, Popovic EA. A population-based study of brain arteriovenous malformation: long-term treatment outcomes. Stroke. 2002;33:2794-2800.
338. Di Rocco C, Tamburrini G, Rollo M. Cerebral arteriovenous malformations in children. Acta Neurochir (Wien). 2000;142:145-156; discussion 156-158.
339. Smith ER, Butler WE, Ogilvy CS. Surgical approaches to vascular anomalies of the child's brain. Curr Opin Neurol. 2002;15:165-171.
340. Fullerton HJ, Achrol AS, Johnston SC, McCulloch CE, Higashida RT, Lawton MT, Sidney S, Young WL. Long-term hemorrhage risk in children versus adults with brain arteriovenous malformations. Stroke. 2005;36:2099-2104.
341. Stapf C, Khaw AV, Sciacca RR, Hofmeister C, Schumacher HC, Pile-Spellman J, Mast H, Mohr JP, Hartmann A. Effect of age on clinical and morphological characteristics in patients with brain arteriovenous malformation. Stroke. 2003;34:2664-2669.
342. Vorstman EB, Niemann DB, Molyneux AJ, Pike MG. Benign intra-cranial hypertension associated with arteriovenous malformation. Dev Med Child Neurol. 2002;44:133-135.
343. Aesch B, Lioret E, de Toffol B, Jan M. Multiple cerebral angiomas and Rendu-Osler-Weber disease: case report. Neurosurgery. 1991;29: 599-602.
344. Willinsky RA, Lasjaunias P, Terbrugge K, Burrows P. Multiple cerebral arteriovenous malformations (AVMs). Review of our experience from 203 patients with cerebral vascular lesions. Neuroradiology. 1990;32: 207-210.
345. Mei-Zahav M, Letarte M, Faughnan ME, Abdalla SA, Cymerman U, MacLusky IB.
346. Matsubara S, Mandzia JL, ter Brugge K, Willinsky RA, Faughnan ME. Angiographic and clinical characteristics of patients with cerebral arte-riovenous malformations associated with hereditary hemorrhagic telangiectasia. AJNR Am J Neuroradiol. 2000;21:1016-1020.
347. Goto S, Abe M, Tsuji T, Tabuchi K. Familial arteriovenous malformations of the brain-two case reports. Neurol Med Chir (Tokyo). 1994; 34:221-224.
348. Liu AC, Segaren N, Cox TS, Hayward RD, Chong WK, Ganesan V, Saunders DE. Is there a role for magnetic resonance imaging in the evaluation of non-traumatic intraparenchymal haemorrhage in children? Pediatr Radiol. 2006;36:940-946.
349. Kondziolka D, Humphreys RP, Hoffman HJ, Hendrick EB, Drake JM. Arteriovenous malformations of the brain in children: a forty year experience. Can J Neurol Sci. 1992;19:40-45.
350. Fullerton HJ, Wu YW, Sidney S, Johnston SC. Recurrent hemorrhagic stroke in children: a population-based cohort study. Stroke. 2007;38: 2658-2662.
351. Kiriş T, Sencer A, Sahinbas M, Sencer S, Imer M, Izgi N. Surgical results in pediatric Spetzler-Martin grades I-III intracranial arterio-venous malformations. Childs Nerv Syst. 2005;21:69-74; discussion 75-76.
352. Sanchez-Mejia RO, Chennupati SK, Gupta N, Fullerton H, Young WL, Lawton MT. Superior outcomes in children compared with adults after microsurgical resection of brain arteriovenous malformations. J Neurosurg. 2006;105(suppl):82-87.
353. Richling B, Killer M, Al-Schameri AR, Ritter L, Agic R, Krenn M. Therapy of brain arteriovenous malformations: multimodality treatment from a balanced standpoint. Neurosurgery. 2006;59(suppl 3):S148-S157; discussion S3-S13.
354. Hoh BL, Ogilvy CS, Butler WE, Loeffler JS, Putman CM, Chapman PH. Multimodality treatment of nongalenic arteriovenous malformations in pediatric patients. Neurosurgery. 2000;47:346 -357; discussion 357-358.
355. Fleetwood IG, Steinberg GK. Arteriovenous malformations. Lancet. 2002;359:863-873.
356. Moriarity JL, Clatterbuck RE, Rigamonti D. The natural history of cavernous malformations. Neurosurg Clin N Am. 1999;10:411-417.
357. Revencu N, Vikkula M. Cerebral cavernous malformation: new molecular and clinical insights. J Med Genet. 2006;43:716-721.
358. Denier C, Goutagny S, Labauge P, Krivosic V, Arnoult M, Cousin A, Benabid AL, Comoy J, Frerebeau P, Gilbert B, Houtteville JP, Jan M, Lapierre F, Loiseau H, Menei P, Mercier P, Moreau JJ, Nivelon-Chevallier A, Parker F, Redondo AM, Scarabin JM, Tremoulet M, Zerah M, Maciazek J, Tournier-Lasserve E; Société Française de Neurochirurgie. Mutations within the MGC4607 gene cause cerebral cavernous malformations. Am J Hum Genet. 2004;74:326-337.
359. Liquori CL, Berg MJ, Siegel AM, Huang E, Zawistowski JS, Stoffer T, Verlaan D, Balogun F, Hughes L, Leedom TP, Plummer NW, Cannella M, Maglione V, Squitieri F, Johnson EW, Rouleau GA, Ptacek L, Marchuk DA. Mutations in a gene encoding a novel protein containing a phosphotyrosine-binding domain cause type 2 cerebral cavernous malformations. Am J Hum Genet. 2003;73:1459-1464.
360. Gunel M, Awad IA, Finberg K, Anson JA, Steinberg GK, Batjer HH, Kopitnik TA, Morrison L, Giannotta SL, Nelson-Williams C, Lifton RP. A founder mutation as a cause of cerebral cavernous malformation in Hispanic Americans. N Engl J Med. 1996;334:946-951.
361. Frima-Verhoeven PA, Op de Coul AA, Tijssen CC, Maat B. Intracranial cavernous angiomas: diagnosis and therapy. Eur Neurol. 1989;29: 56-60.
362. Lehnhardt FG, von Smekal U, Rückriem B, Stenzel W, Neveling M, Heiss WD, Jacobs AH. Value of gradient-echo magnetic resonance imaging in the diagnosis of familial cerebral cavernous malformation. Arch Neurol. 2005;62:653-658.
363. Lee JW, Kim DS, Shim KW, Chang JH, Huh SK, Park YG, Choi JU. Management of intracranial cavernous malformation in pediatric patients. Childs Nerv Syst. 2008;24:321-327.
364. Batjer HH, Reisch JS, Allen BC, Plaizier LJ, Su CJ. Failure of surgery to improve outcome in hypertensive putaminal hemorrhage. A prospective randomized trial. Arch Neurol. 1990;47:1103-1106.
365. Tan SH, Ng PY, Yeo TT, Wong SH, Ong PL, Venketasubramanian N. Hypertensive basal ganglia hemorrhage: a prospective study comparing surgical and nonsurgical management. Surg Neurol. 2001;56:287-292.
366. Mendelow AD, Gregson BA, Fernandes HM, Murray GD, Teasdale GM, Hope DT, Karimi A, Shaw MD, Barer DH; STICH investigators. Early surgery versus initial conservative treatment in patients with spontaneous supratentorial intracerebral haematomas in the International Surgical Trial in Intracerebral Haemorrhage (STICH): a randomised trial. Lancet. 2005;365:387-397.
367. Morgenstern LB, Demchuk AM, Kim DH, Frankowski RF, Grotta JC. Rebleeding leads to poor outcome in ultra-early craniotomy for intrace-rebral hemorrhage. Neurology. 2001;56:1294-1299.
368. Puzzilli F, Salvati M, Bristot R, Raco A, Ruggeri A, Bastianello S, Lunardi P. Spontaneous cerebellar haemorrhages in childhood. Childs Nerv Syst. 1997;13:601-603; discussion 604.
369. Shin M, Kawamoto S, Kurita H, Tago M, Sasaki T, Morita A, Ueki K, Kirino T. Retrospective analysis of a 10-year experience of stereotactic radio surgery for arteriovenous malformations in children and adolescents. J Neurosurg. 2002;97:779-784.
370. Smyth MD, Sneed PK, Ciricillo SF, Edwards MS, Wara WM, Larson DA, Lawton MT, Gutin PH, McDermott MW. Stereotactic radiosurgery for pediatric intracranial arteriovenous malformations: the University of California at San Francisco experience. J Neurosurg. 2002;97:48-55.
371. Levy EI, Niranjan A, Thompson TP, Scarrow AM, Kondziolka D, Flickinger JC, Lunsford LD. Radiosurgery for childhood intracranial arteriovenous malformations. Neurosurgery. 2000;47:834 - 841, discussion 841-842.
372. Cohen-Gadol AA, Pollock BE. Radiosurgery for arteriovenous malformations in children. J Neurosurg. 2006;104(suppl):388-391.
373. Bederson JB, Awad IA, Wiebers DO, Piepgras D, Haley EC Jr, Brott T, Hademenos G, Chyatte D, Rosenwasser R, Caroselli C. Recommendations for the management of patients with unruptured intracranial aneurysms: a statement for healthcare professionals from the Stroke Council of the American Heart Association. Circulation. 2000;102: 2300-2308.
374. Bousser MG, Ross Russell R. Cerebral Venous Thrombosis, Vol. 1. London, United Kingdom: WB Saunders Co; 1997:175.
375. Biousse V, Ameri A, Bousser MG. Isolated intracranial hypertension as the only sign of cerebral venous thrombosis. Neurology. 1999;53: 1537-1542.
376. Cumurciuc R, Crassard I, Sarov M, Valade D, Bousser MG. Headache as the only neurological sign of cerebral venous thrombosis: a series of 17 cases. J Neurol Neurosurg Psychiatry. 2005;76:1084-1087.
377. Norrell H, Wilson C, Howieson J, Megison L, Bertan V. Venous factors in infantile hydrocephalus. J Neurosurg. 1969;31:561-569.
378. Marquardt G, Weidauer S, Lanfermann H, Seifert V. Cerebral venous sinus thrombosis manifesting as bilateral subdural effusion. Acta Neurol Scand. 2004;109:425-428.
379. Adaletli I, Sirikci A, Kara B, Kurugoglu S, Ozer H, Bayram M. Cerebral venous sinus thrombosis presenting with excessive subarachnoid hemorrhage in a 14-year-old boy. Emerg Radiol. 2005;12:57-59.
380. Wasay M, Dai AI, Ansari M, Shaikh Z, Roach ES. Cerebral venous sinus thrombosis in children: a multicenter cohort from the United States. J Child Neurol. 2008;23:26 -31.
381. Kastenbauer S, Pfister HW. Pneumococcal meningitis in adults: spectrum of complications and prognostic factors in a series of 87 cases. Brain. 2003;126:1015-1025.
382. Keane S, Gallagher A, Ackroyd S, McShane MA, Edge JA. Cerebral venous thrombosis during diabetic ketoacidosis. Arch Dis Child. 2002; 86:204-205.
383. Packer RJ, Rorke LB, Lange BJ, Siegel KR, Evans AE. Cerebrovascular accidents in children with cancer. Pediatrics. 1985;76:194 -201.
384. Kao A, Dlugos D, Hunter JV, Mamula P, Thorarensen O. Anticoagu-lation therapy in cerebral sinovenous thrombosis and ulcerative colitis in children. J Child Neurol. 2002;17:479-482.
385. Uziel Y, Laxer RM, Blaser S, Andrew M, Schneider R, Silverman ED. Cerebral vein thrombosis in childhood systemic lupus erythematosus. J Pediatr. 1995;126:722-727.
386. Siegert CE, Smelt AH, de Bruin TW. Superior sagittal sinus thrombosis and thyrotoxicosis. Possible association in two cases. Stroke. 1995;26: 496-497.
387. Meena AK, Naidu KS, Murthy JM. Cortical sinovenous thrombosis in a child with nephrotic syndrome and iron deficiency anaemia. Neurol India. 2000;48:292-294.
388. Shiozawa Z, Ueda R, Mano T, Tsugane R, Kageyama N. Superior sagittal sinus thrombosis associated with Evans' syndrome of hae-molytic anaemia. J Neurol. 1985;232:280-282.
389. Incorpora G, Di Gregorio F, Romeo MA, Pavone P, Trifiletti RR, Parano E. Focal neurological deficits in children with beta-thalassemia major. Neuropediatrics. 1999;30:45-48.
390. Garcia JH. Thrombosis of cranial veins and sinuses: brain parenchymal effects. In: Einhäupl K, Kempski O, Baethmann A, eds. Cerebral Sinus Thrombosis: Experimental and Clinical Aspects. New York, NY: Plenum Press; 1990:27-38.
391. Oguz M, Aksungur EH, Soyupak SK, Yildirim AU. Vein of Galen and sinus thrombosis with bilateral thalamic infarcts in sickle cell anaemia: CT follow-up and angiographic demonstration. Neuroradiology. 1994; 36:155-156.
392. Di Roio C, Jourdan C, Yilmaz H, Artru F. [Cerebral deep vein thrombosis: three cases]. Rev Neurol (Paris). 1999;155:583-587.
393. van Mierlo TD, van den Berg HM, Nievelstein RA, Braun KP. An unconscious girl with sickle-cell disease. Lancet. 2003;361:136.
394. Belman AL, Roque CT, Ancona R, Anand AK, Davis RP. Cerebral venous thrombosis in a child with iron deficiency anemia and thrombocytosis. Stroke. 1990;21:488-493.
395. Hartfield DS, Lowry NJ, Keene DL, Yager JY. Iron deficiency: a cause of stroke in infants and children. Pediatr Neurol. 1997;16:50-53.
396. Benedict SL, Bonkowsky JL, Thompson JA, Van Orman CB, Boyer RS, Bale JF Jr, Filloux FM. Cerebral sinovenous thrombosis in children: another reason to treat iron deficiency anemia. J Child Neurol. 2004; 19:526-531.
397. Bonduel M, Sciuccati G, Hepner M, Torres AF, Pieroni G, Frontroth JP. Prethrombotic disorders in children with arterial ischemic stroke and sinovenous thrombosis. Arch Neurol. 1999;56:967-971.
398. Yuen P, Cheung A, Lin HJ, Ho F, Mimuro J, Yoshida N, Aoki N. Purpura fulminans in a Chinese boy with congenital protein C deficiency. Pediatrics. 1986;77:670-676.
399. Tarras S, Gadia C, Meister L, Roldan E, Gregorios JB. Homozygous protein C deficiency in a newborn. Clinicopathologic correlation. Arch Neurol. 1988;45:214-216.
400. Cakmak S, Derex L, Berruyer M, Nighoghossian N, Philippeau F, Adeleine P, Hermier M, Froment JC, Trouillas P. Cerebral venous thrombosis: clinical outcome and systematic screening of prothrombotic factors. Neurology. 2003;60:1175-1178.
401. Lüdemann P, Nabavi DG, Junker R, Wolff E, Papke K, Buchner H, Assmann G, Ringelstein EB. Factor V Leiden mutation is a risk factor for cerebral venous thrombosis: a case-control study of 55 patients. Stroke. 1998;29:2507-2510.
402. Reuner KH, Ruf A, Grau A, Rickmann H, Stolz E, Jüttler E, Druschky KF, Patscheke H. Prothrombin gene G20210->A transition is a risk factor for cerebral venous thrombosis. Stroke. 1998;29:1765-1769.
403. Hillier CE, Collins PW, Bowen DJ, Bowley S, Wiles CM. Inherited prothrombotic risk factors and cerebral venous thrombosis. QJM. 1998; 91:677-680.
404. Bonduel M, Sciuccati G, Hepner M, Pieroni G, Torres AF, Mardaraz C, Frontroth JP. Factor V Leiden and prothrombin gene G20210A mutation in children with cerebral thromboembolism. Am J Hematol. 2003;73: 81-86.
405. Johnson MC, Parkerson N, Ward S, de Alarcon PA. Pediatric sinovenous thrombosis. J Pediatr Hematol Oncol. 2003;25:312-315.
406. Kenet G, Kirkham F, Niederstadt T, Heinecke A, Saunders D, Stoll M, Brenner B, Bidlingmaier C, Heller C, Knöfler R, Schobess R, Zieger B, Sébire G, Nowak-Göttl U; European Thromboses Study Group. Risk factors for recurrent venous thromboembolism in the European collaborative paediatric database on cerebral venous thrombosis: a multicentre cohort study. Lancet Neurol. 2007;6:595-603.
407. Martinelli I, Battaglioli T, Pedotti P, Cattaneo M, Mannucci PM. Hyper-homocysteinemia in cerebral vein thrombosis. Blood. 2003;102: 1363-1366.
408. Cantu C, Alonso E, Jara A, Martínez L, Ríos C, Fernández Mde L, Garcia I, Barinagarrementeria F. Hyperhomocysteinemia, low folate and vitamin B12 concentrations, and methylene tetrahydrofolate reductase mutation in cerebral venous thrombosis. Stroke. 2004;35:1790-1794.
409. Baumgartner RW, Studer A, Arnold M, Georgiadis D. Recanalisation of cerebral venous thrombosis. J Neurol Neurosurg Psychiatry. 2003;74: 459-461.
410. Huisman TA, Holzmann D, Martin E, Willi UV. Cerebral venous thrombosis in childhood. Eur Radiol. 2001;11:1760-1765.
411. Davies RP, Slavotinek JP. Incidence of the empty delta sign in computed tomography in the paediatric age group. Australas Radiol. 1994;38: 17-19.
412. Barnes C, Newall F, Furmedge J, Mackay M, Monagle P. Cerebral sinus venous thrombosis in children. J Paediatr Child Health. 2004;40:53-55.
413. Forbes KP, Pipe JG, Heiserman JE. Evidence for cytotoxic edema in the pathogenesis of cerebral venous infarction. AJNR Am J Neuroradiol. 2001;22:450-455.
414. Medlock MD, Olivero WC, Hanigan WC, Wright RM, Winek SJ. Children with cerebral venous thrombosis diagnosed with magnetic resonance imaging and magnetic resonance angiography. Neurosurgery. 1992;31:870-876; discussion 876.
415. Selim M, Fink J, Linfante I, Kumar S, Schlaug G, Caplan LR. Diagnosis of cerebral venous thrombosis with echo-planar T2*-weighted magnetic resonance imaging. Arch Neurol. 2002;59:1021-1026.
416. Einhaupl KM, Villringer A, Meister W, Mehraein S, Garner C, Pellkofer M, Haberl RL, Pfister HW, Schmiedek P. Heparin treatment in sinus venous thrombosis. Lancet. 1991;338:597-600.
417. de Bruijn SF, Stam J. Randomized, placebo-controlled trial of anticoagulant treatment with low-molecular-weight heparin for cerebral sinus thrombosis. Stroke. 1999;30:484-488.
418. Stam J, De Bruijn SF, DeVeber G. Anticoagulation for cerebral sinus thrombosis. Cochrane Database Syst Rev. 2002:CD002005.
419. Griesemer DA, Theodorou AA, Berg RA, Spera TD. Local fibrinolysis in cerebral venous thrombosis. Pediatr Neurol. 1994;10:78-80.
420. Soleau SW, Schmidt R, Stevens S, Osborn A, MacDonald JD. Extensive experience with dural sinus thrombosis. Neurosurgery. 2003;52: 534-544; discussion 542-544.
421. Liebetrau M, Mayer TE, Bruning R, Opherk C, Hamann GF. Intra-ar-terial thrombolysis of complete deep cerebral venous thrombosis. Neurology. 2004;63:2444-2445.
422. Chahlavi A, Steinmetz MP, Masaryk TJ, Rasmussen PA. A transcranial approach for direct mechanical thrombectomy of dural sinus thrombosis. Report of two cases. J Neurosurg. 2004;101:347-351.
423. Stefini R, Latronico N, Cornali C, Rasulo F, Bollati A. Emergent decompressive craniectomy in patients with fixed dilated pupils due to cerebral venous and dural sinus thrombosis: report of three cases. Neurosurgery. 1999;45:626-629; discussion 629-630.
424. Keller E, Pangalu A, Fandino J, Könü D, Yonekawa Y. Decompressive craniectomy in severe cerebral venous and dural sinus thrombosis. Acta Neurochir Suppl. 2005;94:177-183.
425. Ciccone A, Canhão P, Falcão F, Ferro JM, Sterzi R. Thrombolysis for cerebral vein and dural sinus thrombosis. Cochrane Database Syst Rev. 2004:CD003693.
426. Wasay M, Bakshi R, Kojan S, Bobustuc G, Dubey N, Unwin DH. Nonrandomized comparison of local urokinase thrombolysis versus systemic heparin anticoagulation for superior sagittal sinus thrombosis. Stroke. 2001;32:2310-2317.
427. Canhão P, Ferro JM, Lindgren AG, Bousser MG, Stam J, Barinagarre-menteria F; ISCVT Investigators. Causes and predictors of death in cerebral venous thrombosis. Stroke. 2005;36:1720-1725.
428. Petzold A, Smith M. High intracranial pressure, brain herniation and death in cerebral venous thrombosis. Stroke. 2006;37:331-332.
429. Hetherington R, Tuff L, Anderson P, Miles B, deVeber G. Short-term intellectual outcome after arterial ischemic stroke and sinovenous thrombosis in childhood and infancy. J Child Neurol. 2005;20:553-559.
430. Higashida RT, Helmer E, Halbach VV, Hieshima GB. Direct thrombolytic therapy for superior sagittal sinus thrombosis. AJNR Am J Neuroradiol. 1989;10(suppl):S4-S6.
431. Wong VK, LeMesurier J, Franceschini R, Heikali M, Hanson R. Cerebral venous thrombosis as a cause of neonatal seizures. Pediatr Neurol. 1987;3:235-237.
432. Ganesan V, Savvy L, Chong WK, Kirkham FJ. Conventional cerebral angiography in children with ischemic stroke. Pediatr Neurol. 1999;20: 38-42.
433. Husson B, Lasjaunias P. Radiological approach to disorders of arterial brain vessels associated with childhood arterial stroke: a comparison between MRA and contrast angiography. Pediatr Radiol. 2004;34: 10-15.
434. Rollins N, Dowling M, Booth T, Purdy P. Idiopathic ischemic cerebral infarction in childhood: depiction of arterial abnormalities by MR angiography and catheter angiography. AJNR Am J Neuroradiol. 2000; 21:549-556.
435. Childs AM, Cornette L, Ramenghi LA, Tanner SF, Arthur RJ, Martinez D, Levene MI. Magnetic resonance and cranial ultrasound characteristics of periventricular white matter abnormalities in newborn infants. Clin Radiol. 2001;56:647-655.
436. Ilves P, Talvik R, Talvik T. Changes in Doppler ultrasonography in asphyxiated term infants with hypoxic-ischaemic encephalopathy. Acta Paediatr. 1998;87:680-684.
437. Rabe H, Grohs B, Schmidt RM, Schloo R, Bömelburg T, Jorch G. Acoustic power measurements of Doppler ultrasound devices used for perinatal and infant examinations. Pediatr Radiol. 1990;20:277-281.
438. Wang WC, Gallagher DM, Pegelow CH, Wright EC, Vichinsky EP, Abboud MR, Moser FG, Adams RJ. Multicenter comparison of magnetic resonance imaging and transcranial Doppler ultrasonography in the evaluation of the central nervous system in children with sickle cell disease. J Pediatr Hematol Oncol. 2000;22:335-339.
439. Abboud MR, Cure J, Granger S, Gallagher D, Hsu L, Wang W, Woods G, Berman B, Brambilla D, Pegelow C, Lewin J, Zimmermann RA, Adams RJ; STOP study. Magnetic resonance angiography in children with sickle cell disease and abnormal transcranial Doppler ultra-sonography findings enrolled in the STOP study. Blood. 2004;103: 2822-2826.
440. Kogutt MS, Goldwag SS, Gupta KL, Kaneko K, Humbert JR. Correlation of transcranial Doppler ultrasonography with MRI and MRA in the evaluation of sickle cell disease patients with prior stroke. Pediatr Radiol. 1994;24:204-206.
441. Sloan MA, Alexandrov AV, Tegeler CH, Spencer MP, Caplan LR, Feldmann E, Wechsler LR, Newell DW, Gomez CR, Babikian VL, Lefkowitz D, Goldman RS, Armon C, Hsu CY, Goodin DS; Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Assessment: transcranial Doppler ultra-sonography: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology. 2004;62:1468-1481.
442. Johnson MB, Wilkinson ID, Wattam J, Venables GS, Griffiths PD. Comparison of Doppler ultrasound, magnetic resonance angiographic techniques and catheter angiography in evaluation of carotid stenosis. Clin Radiol. 2000;55:912-920.
443. Eliasziw M, Rankin RN, Fox AJ, Haynes RB, Barnett HJ. Accuracy and prognostic consequences of ultrasonography in identifying severe carotid artery stenosis. North American Symptomatic Carotid Endarter-ectomy Trial (NASCET) Group. Stroke. 1995;26:1747-1752.
444. Soo OY, Chan YL, Wong KS. Carotid artery dissection after prolonged head tilting while holding a newborn baby to sleep. Neurology. 2004; 62:1647-1648.
445. Iannuzzi A, Licenziati MR, Acampora C, Salvatore V, Auriemma L, Romano ML, Panico S, Rubba P, Trevisan M. Increased carotid intima-media thickness and stiffness in obese children. Diabetes Care. 2004;27:2506-2508.
446. Krantz JS, Mack WJ, Hodis HN, Liu CR, Liu CH, Kaufman FR. Early onset of subclinical atherosclerosis in young persons with type 1 diabetes. J Pediatr. 2004;145:452- 457.
447. Kilpatrick MM, Yonas H, Goldstein S, Kassam AB, Gebel JM Jr, Wechsler LR, Jungreis CA, Fukui MB. CT-based assessment of acute stroke: CT, CT angiography, and xenon-enhanced CT cerebral blood flow. Stroke. 2001;32:2543-2549.
448. Nabavi DG, Kloska SP, Nam EM, Freund M, Gaus CG, Klotz E, Heindel W, Ringelstein EB. MOSAIC: Multimodal Stroke Assessment Using Computed Tomography: novel diagnostic approach for the prediction of infarction size and clinical outcome. Stroke. 2002;33: 2819-2826.
449. Brenner D, Elliston C, Hall E, Berdon W. Estimated risks of radiation-induced fatal cancer from pediatric CT. AJR Am J Roentgenol. 2001; 176:289-296.
450. Hirata M, Sugawara Y, Fukutomi Y, Oomoto K, Murase K, Miki H, Mochizuki T. Measurement of radiation dose in cerebral CT perfusion study. Radiat Med. 2005;23:97-103.
451. Bahner ML, Bengel A, Brix G, Zuna I, Kauczor HU, Delorme S. Improved vascular opacification in cerebral computed tomography angiography with 80 kVp. Invest Radiol. 2005;40:229-234.
452. Frush DP, Slack CC, Hollingsworth CL, Bisset GS, Donnelly LF, Hsieh J, Lavin-Wensell T, Mayo JR. Computer-simulated radiation dose reduction for abdominal multidetector CT of pediatric patients. AJR Am J Roentgenol. 2002;179:1107-1113.
453. Donnelly LF, Emery KH, Brody AS, Laor T, Gylys-Morin VM, Anton CG, Thomas SR, Frush DP. Minimizing radiation dose for pediatric body applications of single-detector helical CT: strategies at a large Children's Hospital. AJR Am J Roentgenol. 2001;176:303-306.
454. Lövblad KO, Laubach HJ, Baird AE, Curtin F, Schlaug G, Edelman RR, Warach S. Clinical experience with diffusion-weighted MR in patients with acute stroke. AJNR Am J Neuroradiol. 1998;19:1061-1066.
455. Yuh WT, Crain MR, Loes DJ, Greene GM, Ryals TJ, Sato Y. MR imaging of cerebral ischemia: findings in the first 24 hours. AJNR Am J Neuroradiol. 1991;12:621-629.
456. van Everdingen KJ, van der Grond J, Kappelle LJ, Ramos LM, Mali WP. Diffusion-weighted magnetic resonance imaging in acute stroke. Stroke. 1998;29:1783-1790.
457. Yenari MA, Palmer JT, Sun GH, de Crespigny A, Mosely ME, Steinberg GK. Time-course and treatment response with SNX-111, an N-type calcium channel blocker, in a rodent model of focal cerebral ischemia using diffusion-weighted MRI. Brain Res. 1996;739:36-45.
458. Warach S, Gaa J, Siewert B, Wielopolski P, Edelman RR. Acute human stroke studied by whole brain echo planar diffusion-weighted magnetic resonance imaging. Ann Neurol. 1995;37:231-241.
459. Noguchi K, Seto H, Kamisaki Y, Tomizawa G, Toyoshima S, Watanabe N. Comparison of fluid-attenuated inversion-recovery MR imaging with CT in a simulated model of acute subarachnoid hemorrhage. AJNR Am J Neuroradiol. 2000;21:923-927.
460. Sunshine JL, Bambakidis N, Tarr RW, Lanzieri CF, Zaidat OO, Suarez JI, Landis DM, Selman WR. Benefits of perfusion MR imaging relative to diffusion MR imaging in the diagnosis and treatment of hyperacute stroke. AJNR Am J Neuroradiol. 2001;22:915-921.
461. Eastwood JD, Lev MH, Wintermark M, Fitzek C, Barboriak DP, Delong DM, Lee TY, Azhari T, Herzau M, Chilukuri VR, Provenzale JM. Correlation of early dynamic CT perfusion imaging with whole-brain MR diffusion and perfusion imaging in acute hemispheric stroke. AJNR Am J Neuroradiol. 2003;24:1869-1875.
462. Gillard JH, Barker PB, van Zijl PC, Bryan RN, Oppenheimer SM. Proton MR spectroscopy in acute middle cerebral artery stroke. AJNR Am J Neuroradiol. 1996;17:873-886.
463. Bluml S, Friedlich P, Erberich S, Wood JC, Seri I, Nelson MD Jr. MR imaging of newborns by using an MR-compatible incubator with integrated radiofrequency coils: initial experience. Radiology. 2004;231: 594-601.
464. Young N, Dorsch NW, Kingston RJ, Markson G, McMahon J. Intra-cranial aneurysms: evaluation in 200 patients with spiral CT angiography. Eur Radiol. 2001;11:123-130.
465. Willinsky RA, Taylor SM, TerBrugge K, Farb RI, Tomlinson G, Mon-tanera W. Neurologic complications of cerebral angiography: prospective analysis of 2,899 procedures and review of the literature. Radiology. 2003;227:522-528.
466. Cohen HC, Tucker WS, Humphreys RP, Perrin RJ. Angiographically cryptic histologically verified cerebrovascular malformations. Neurosurgery. 1982;10:704-714.
467. du Mesnil de Rochemont R, Heindel W, Wesselmann C, Krüger K, Lanfermann H, Ernestus RI, Neveling M, Lackner K. Nontraumatic subarachnoid hemorrhage: value of repeat angiography. Radiology. 1997;202:798-800.
468. Husson B, Rodesch G, Lasjaunias P, Tardieu M, Sébire G. Magnetic resonance angiography in childhood arterial brain infarcts: a comparative study with contrast angiography. Stroke. 2002;33:1280 -1285.
469. Monagle P, Chan A, Massicotte P, Chalmers E, Michelson AD. Antithrombotic therapy in children: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004;126(suppl): 645S-687S.
470. DeVeber G. In pursuit of evidence-based treatments for paediatric stroke: the UK and Chest guidelines. Lancet Neurol. 2005;4:432-436.
471. Michenfelder JD, Milde JH. The relationship among canine brain temperature, metabolism, and function during hypothermia. Anesthesiology. 1991;75:130-136.
472. Takagi K. Body temperature in acute stroke. Stroke. 2002;33: 2154-2155; author reply 2154-2155.
473. Schwab S, Georgiadis D, Berrouschot J, Schellinger PD, Graffagnino C, Mayer SA. Feasibility and safety of moderate hypothermia after massive hemispheric infarction. Stroke. 2001;32:2033-2035.
474. Gupta R, Jovin TG, Krieger DW. Therapeutic hypothermia for stroke: do new outfits change an old friend? Expert Rev Neurother. 2005;5: 235-246.
475. Massicotte P, Adams M, Marzinotto V, Brooker LA, Andrew M. Low-molecular-weight heparin in pediatric patients with thrombotic disease: a dose finding study. J Pediatr. 1996;128:313-318.
476. Burak CR, Bowen MD, Barron TF. The use of enoxaparin in children with acute, nonhemorrhagic ischemic stroke. Pediatr Neurol. 2003;29: 295-298.
477. Sträter R, Kurnik K, Heller C, Schobess R, Luigs P, Nowak-Göttl U. Aspirin versus low-dose low-molecular-weight heparin: antithrombotic therapy in pediatric ischemic stroke patients: a prospective follow-up study. Stroke. 2001;32:2554-2558.
478. Cheung YF, Leung MP. Low dose oral anticoagulation therapy in Chinese children with congenital heart disease. J Paediatr Child Health. 2003;34:563-567.
479. Ruud E, Holmstrom H, De Lange C, Hogstad E, Wesenberg F. Low-dose warfarin for the prevention of central line-associated thromboses in children with malignancies-a randomized, controlled study. Acta Paediatr. 2006;95:1053-1059.
480. Sandercock PA, van den Belt AG, Lindley RI, Slattery J. Antithrombotic therapy in acute ischaemic stroke: an overview of the completed randomised trials. J Neurol Neurosurg Psychiatry. 1993;56:17-25.
481. Albers GW, Amarenco P, Easton JD, Sacco RL, Teal P. Antithrombotic and thrombolytic therapy for ischemic stroke. Chest. 2001;119(suppl): 300S-320S.
482. Mohr JP, Thompson JL, Lazar RM, Levin B, Sacco RL, Furie KL, Kistler JP, Albers GW, Pettigrew LC, Adams HP Jr, Jackson CM, Pullicino P; Warfarin-Aspirin Recurrent Stroke Study Group. A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke. N Engl J Med. 2001;345:1444-1451.
483. Soman T, Rafay MF, Hune S, Allen A, MacGregor D, deVeber G. The risks and safety of clopidogrel in pediatric arterial ischemic stroke. Stroke. 2006;37:1120-1122.
484. Carlson MD, Leber S, Deveikis J, Silverstein FS. Successful use of rt-PA in pediatric stroke. Neurology. 2001;57:157-158.
485. Thirumalai SS, Shubin RA. Successful treatment for stroke in a child using recombinant tissue plasminogen activator. J Child Neurol. 2000; 15:558.
486. Kirton A, Wong JH, Mah J, Ross BC, Kennedy J, Bell K, Hill MD. Successful endovascular therapy for acute basilar thrombosis in an adolescent. Pediatrics. 2003;112:e248-e251.
487. Benedict SL, Ni OK, Schloesser P, White KS, Bale JF Jr. Intra-arterial thrombolysis in a 2-year-old with cardioembolic stroke. J Child Neurol. 2007;22:225-227.
488. Horowitz M, Purdy P, Unwin H, Carstens G 3rd, Greenlee R, Hise J, Kopitnik T, Batjer H, Rollins N, Samson D. Treatment of dural sinus thrombosis using selective catheterization and urokinase. Ann Neurol. 1995;38:58-67.
489. Gupta AA, Leaker M, Andrew M, Massicotte P, Liu L, Benson LN, McCrindle BW. Safety and outcomes of thrombolysis with tissue plasminogen activator for treatment of intravascular thrombosis in children. J Pediatr. 2001;139:682-688.
490. Janjua N, Nasar A, Lynch JK, Qureshi AI. Thrombolysis for ischemic stroke in children: data from the nationwide inpatient sample. Stroke. 2007;38:1850-1854.
491. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med. 1995;333:1581-1587.
492. Manco-Johnson MJ, Grabowski EF, Hellgreen M, Kemahli AS, Mas-sicotte MP, Muntean W, Peters M, Schlegel N, Wang M, Nowak-Göttl U. Recommendations for tPA thrombolysis in children. On behalf of the Scientific Subcommittee on Perinatal and Pediatric Thrombosis of the Scientific and Standardization Committee of the International Society of Thrombosis and Haemostasis. Thromb Haemost. 2002;88:157-158.
493. Gabis LV, Yangala R, Lenn NJ. Time lag to diagnosis of stroke in children. Pediatrics. 2002;110:924-928.
494. Wang M, Hays T, Balasa V, Bagatell R, Gruppo R, Grabowski EF, Valentino LA, Tsao-Wu G, Manco-Johnson MJ; Pediatric Coagulation Consortium. Low-dose tissue plasminogen activator thrombolysis in children. J Pediatr Hematol Oncol. 2003;25:379-386.
495. Golomb MR. The contribution of prothrombotic disorders to peri- and neonatal ischemic stroke. Semin Thromb Hemost. 2003;29:415-424.
496. Curry CJ, Bhullar S, Holmes J, Delozier CD, Roeder ER, Hutchison HT. Risk factors for perinatal arterial stroke: a study of 60 mother-child pairs. Pediatr Neurol. 2007;37:99 -107.
497. Bucciarelli P, Rosendaal FR, Tripodi A, Mannucci PM, De Stefano V, Palareti G, Finazzi G, Baudo F, Quintavalla R. Risk of venous thromboembolism and clinical manifestations in carriers of antithrombin, protein C, protein S deficiency, or activated protein C resistance: a multicenter collaborative family study. Arterioscler Thromb Vasc Biol. 1999;19:1026-1033.
498. Makris M, Leach M, Beauchamp NJ, Daly ME, Cooper PC, Hampton KK, Bayliss P, Peake IR, Miller GJ, Preston FE. Genetic analysis, phenotypic diagnosis, and risk of venous thrombosis in families with inherited deficiencies of protein S. Blood. 2000;95:1935-1941.
499. Lensen R, Rosendaal F, Vandenbroucke J, Bertina R. Factor V Leiden: the venous thrombotic risk in thrombophilic families. Br J Haematol. 2000;110:939-945.
500. Martinelli I, Bucciarelli P, Margaglione M, De Stefano V, Castaman G, Mannucci PM. The risk of venous thromboembolism in family members with mutations in the genes of factor V or prothrombin or both. Br J Haematol. 2000;111:1223-1229.
501. Keijzer MB, den Heijer M, Blom HJ, Bos GM, Willems HP, Gerrits WB, Rosendaal FR. Interaction between hyperhomocysteinemia, mutated methylenetetrahydrofolatereductase (MTHFR) and inherited thrombophilic factors in recurrent venous thrombosis. Thromb Haemost. 2002;88:723-728.
502. Ho CH, Kuo BI, Kong CW, Chau WK, Hsu HC, Gau JP, Yu YB. Influence of methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism, B vitamins and other factors on plasma homocysteine and risk of thromboembolic disease in Chinese. J Chin Med Assoc. 2005;68:560-565.
503. Grassi M, Assanelli D, Mozzini C, Albertini F, Salvadori G, Archetti S, Negrini R, Galeazzi G, Pezzini A. Modeling premature occurrence of acute coronary syndrome with atherogenic and thrombogenic risk factors and gene markers in extended families. J Thromb Haemost. 2005;3:2238-2244.
504. Domagala TB, Adamek L, Nizankowska E, Sanak M, Szczeklik A. Mutations C677T and A1298C of the 5,10-methylenetetrahydrofolate reductase gene and fasting plasma homocysteine levels are not associated with the increased risk of venous thromboembolic disease. Blood Coagul Fibrinolysis. 2002;13:423-431.
505. Ray JG, Langman LJ, Vermeulen MJ, Evrovski J, Yeo EL, Cole DE. Genetics University of Toronto Thrombophilia Study in Women (GUTTSI): genetic and other risk factors for venous thromboembolism in women. Curr Control Trials Cardiovasc Med. 2001;2:141-149.
506. Meinardi JR, Middeldorp S, de Kam PJ, Koopman MM, van Pampus EC, Hamulyák K, Prins MH, Büller HR, van der Meer J. Risk of venous thromboembolism in carriers of factor V Leiden with a concomitant inherited thrombophilic defect: a retrospective analysis. Blood Coagul Fibrinolysis. 2001;12:713-720.
507. Martinelli I, Legnani C, Bucciarelli P, Grandone E, De Stefano V, Mannucci PM. Risk of pregnancy-related venous thrombosis in carriers of severe
508. Kupferminc MJ, Eldor A, Steinman N, Many A, Bar-Am A, Jaffa A, Fait G, Lessing JB. Increased frequency of genetic thrombophilia in women with complications of pregnancy. N Engl J Med. 1999;340:9-13.
509. Dizon-Townson DS, Kinney S, Branch DW, Ward K. The factor V Leiden mutation is not a common cause of recurrent miscarriage. J Reprod Immunol. 1997;34:217-223.
510. Bank I, Libourel EJ, Middeldorp S, Van Pampus EC, Koopman MM, Hamulyák K, Prins MH, Van Der Meer J, Büller HR. Prothrombin 20210A mutation: a mild risk factor for venous thromboembolism but not for arterial thrombotic disease and pregnancy-related complications in a family study. Arch Intern Med. 2004;164:1932-1937.
511. Kutteh WH, Park VM, Deitcher SR. Hypercoagulable state mutation analysis in white patients with early first-trimester recurrent pregnancy loss. Fertil Steril. 1999;71:1048-1053.
512. van der Put NM, van den Heuvel LP, Steegers-Theunissen RP, Trijbels FJ, Eskes TK, Mariman EC, den Heyer M, Blom HJ. Decreased methylene tetrahydrofolate reductase activity due to the 677C->T mutation in families with spina bifida offspring. J Mol Med. 1996;74:691-694.
513. Golomb MR, Garg BP, Walsh LE, Williams LS. Perinatal stroke in baby, prothrombotic gene in mom: does this affect maternal health insurance? Neurology. 2005;65:13-16.
514. Callahan ST, Cooper WO. Uninsurance and health care access among young adults in the United States. Pediatrics. 2005;116:88-95.
515. Olson LM, Tang SF, Newacheck PW. Children in the United States with discontinuous health insurance coverage. N Engl J Med. 2005;353: 382-391.
516. McWilliams JM, Zaslavsky AM, Meara E, Ayanian JZ. Health insurance coverage and mortality among the near-elderly. Health Aff (Millwood). 2004;23:223-233.
517. Brenner BR, Nowak-Göttl U, Kosch A, Manco-Johnson M, Laposata M. Diagnostic studies for thrombophilia in women on hormonal therapy, in women during pregnancy, and in children. Arch Pathol Lab Med. 2002; 126:1296-1303.
518. Press RD, Bauer KA, Kujovich JL, Heit JA. Clinical utility of Factor V Leiden (R506Q) testing for the diagnosis and management of thrombotic disorders. Arch Pathol Lab Med. 2002;126:1304-1318.
519. ACOG educational bulletin. Thromboembolism in pregnancy. Number 234, March 1997. American College of Obstetricians and Gynecologists. Int J Gynaecol Obstet. 1997;57:209-218.
520. Grody WW, Griffin JH, Taylor AK, Korf BR, Heit JA; ACMG Factor V. Leiden Working Group. American College of Medical Genetics consensus statement on factor V Leiden mutation testing. Genet Med. 2001;3:139-148.
521. Royal College of Obstetricians and Gynaecologists. Venous thromboembolism and oral contraception. Available at: http://www.rcog.org.uk/ resources/Public/pdf/VTE-hormonal-contraception.pdf. Accessed May 13, 2008.
522. Guidelines and Audit Committee of the Royal College of Obstetricians and Gynaecologists. Hormone replacement therapy and venous thromboembolism. Guideline 19; 2004. Available at: http://www.rcog.org.uk/ resources/Public/pdf/ HRT-Venous-Thromboembolism-no19.pdf. Accessed May 13, 2008.
523. Biller J, Mathews KD, Love BB. Stroke in Children and Young Adults. Boston, MA: Butterworth-Heinemann; 1994.
524. Michelson AD, Bovill E, Andrew M. Antithrombotic therapy in children. Chest. 1995;108(suppl):506S-522S.